The Minnesota Pharmacists Foundation Is an Organization That Invests in Public Health Through the Profession of Pharmacy

McKesson Delivers the Industry’s Best Service

So You Can Focus on What Really Matters: Your Patients

Success begins with knowing your CallCall todaytoday toto learn how McKessonMcKesson business. Your McKesson representative cancan helphelp buildbuild youryour independentindependent will conduct an annual profitability pharmacy’spharmacy’s success. success. analysis to track your strengths, find new opportunities, and understand KimKim Diemand,Diemand Vice President Sales your unique business issues. ToddVice President-RxOwnershipBender, District Sales Manager LittleNorth Canada Central DistributionRegion Center Being your strategic advisor is just the 651.484.4811 start. With McKesson, you'll get the Todd Bender industry's best service and innovative District Sales Manager programs that can help you enhance Little Canada Distribution Center profitability—from managed care and 651.484.4811 generics, to automation and best-in- class front-end services.

Most important, you'll get a partner committed to promoting your interests so you can focus on providing the personalized care that sets you apart.

2 Minnesota Pharmacist n Winter 2012 MPhA Board of Directors Executive/Finance Committee: President: Scott Setzepfandt Past-President: Brent Thompson President-Elect: Martin Erickson Secretary-Treasurer: Bill Diers Speaker: Meghan Kelly Executive Vice President: Julie K . Johnson Rural Board Members: Eric Slindee Mark Trumm Metro Board Members: Cheng Lo James Marttila Winter 2012 Volume 66. Number 1, ISSN 0026-5616 At-Large Board Members: Tiffany Elton Tim Cernohous Amy Sapola Jill Strykowski in this issue Jason Varin President’s Desk A Valuable Insight: Patients Appreciate Extra Effort...... 4 Student Representation: Duluth MPSA Liaison: Jeremy LeBlanc Executive’s Report Minneapolis MPSA Liaison: Kandace Schuft Remembering the Dream Weaver...... 7 Ex-Officio: pharmacy and the law Rod Carter, COP Recordkeeping Isn’t that Important, is it?...... 16 Julie K . Johnson, MPhA MSHP Representative features Pharmacy Technician Representative: Walgreens: “America’s Premier Pharmacy” Lives Up to its Self-Image ...... 8 Drug Dosing Based on Kidney Function: A Survey of Minnesota Pharmacists. . . . 10 Barb Stodola Minnesota Practice-Based Research Network: An Update...... 14 Home Care: A New Frontier for Pharmacy Practice ...... 18 MINNESOTA PHARMACIST ...... 19 Official publication of the Minnesota Pharmacists Association. MPhA Information MPhA is an affiliate of the American Pharmacists Association, Committees and Task Forces...... 22 the American Society of Consultant Pharmacists, the Academy of Managed Care Pharmacy, and the National Community MPhA Benefits ...... 23 Pharmacists Association. Community Pharmacy Defense Fund...... 24 Editor: Pharmacy Future Fund ...... 25 Julie K . Johnson ...... 26 Managing Editor, Design and Production: MPhA Award Nomination Form Anna Wrisky Legislative Directory...... 29 The Minnesota Pharmacist (ISSN # 0026-5616) journal Pharmacy Resources...... 33 is published quarterly by the Minnesota Pharmacists Association, 1000 Westgate Drive, Suite 252, St . Paul, 2012 MphA Award Categories...... 34 MN 55114-1469 . Phone: 651-697-1771 or 1-800-451- 8349, 651-290-2266 fax, info@mpha .org . Periodicals postage paid at St . Paul, MN (USPS-352040) . Advertisers Postmaster: Send address changes to Minnesota Pharmacists Association, 1000 Westgate Drive, Suite 252, Dakota Drug Inc ...... 40 St . Paul, MN 55114-1469 . McKesson ...... 2, 39 Article Submission/advertising: For writer’s Minnesota Pharmacists Foundation...... 35 guidelines, article submission, or advertising opportunities, contact the editor at the above address or email julie@ MPhA Career Center...... 9 mpha .org . PACE Alliance...... 17, 39 Bylined articles express the opinion of the contribu- Pharmcists Mutual Companies ...... 6 tors and do not necessarily reflect the position of the Minnesota Pharmacists Association . Articles printed in this Pharm PAC...... 28 publication may not be reproduced in any manner, either Pharmacy Quality Commitment...... 13 in whole or in part, without specific written permission of the publisher . Acceptance of advertisement does not indicate endorsement . Minnesota Pharmacist n Winter 2012 3 president’s desk A Valuable Insight: Patients Appreciate Extra Effort by Scott Setzepfandt, RPh, MPhA President

“Thank you, Tia!” Get out from behind One of the more rewarding aspects of being a community phar- the counter and ask! macist is when your patient thanks you for providing good counseling, especially when you aren’t expecting it . Pharmacists are well trained to provide good drug therapy man- improvement; along with increased exercise he recommended agement . They do it every day, and for the most part don’t even I start taking niacin . So there I was, checking out the nutrition think about the valuable service they are providing . It’s a humble shelves looking for it . bunch of professionals who really don’t expect accolades for doing Out from behind the counter came Tia Paulson, PharmD . She their job well . On the other hand, there are barriers in place that asked me if I needed any help . Always curious about how well make it difficult to do just that . pharmacists counsel, I put my patient hat on and played ignorant A study was reported in the Journal of the American Pharmacist (some would argue that isn’t a hard task for me…but that’s a Association last summer that looked at pharmacy services from whole different article) . I told Tia my doctor advised that I start the patient perspective 1. In that study, more than 90% of those taking niacin daily and asked what the difference was and what surveyed indicated a desire for pharmacist-provided information she would recommend . She explained the differences of the ones or that written material was insufficient when obtaining a new they had in stock, told me about what type of side effect I might prescription . Even on refills, nearly half surveyed indicated they experience and recommended when I should take it . It was a short wanted more information than simply how many refills were left . exchange but she answered all of my questions clearly and in a reassuring manner . The study also looked at barriers to getting the information they desired . One might think the obvious barrier is a lack of privacy I put the bottle in my cart and went about finishing the rest of my due to the layout of the pharmacy . Surprisingly, from the patients’ shopping . As I rolled my cart around the store I reflected on how perspective, this came up only 4% of the time . It is reassuring, nice an exchange that was, how interested Tia seemed in my well- too, that only 1 .5% indicated they did not trust the pharmacist being, and how useful her information would be for the patient to provide good information . On the other hand, the perception who has no real health care background . I also thought about how that pharmacists were not “approachable” came up 18 .7% of the rarely the pharmacist is made aware that what they did was very time . But 63% of the patients reported the largest barrier was the much appreciated . Sure, I gave Tia a typical “thanks,” but it just patient him/herself . Reasons cited: lacking time 9 .7%, perceiv- didn’t seem like enough . ing no need for info 9 .7%, lacking initiative 20 .0% and fear or So before I left the store I went back to thank Tia . I told her embarrassment at 24 .2% . who I was, thanked her again for doing a great job of counseling The article contains much more data, but suffice to say patients and asked if it was OK if I mentioned her in my next article for want to interact and receive information from pharmacists — but MPhA . She was surprised and blushed a little . But I believe she, as aren’t motivated or sure how to do so or are restrained by fear well as all of you who take that extra effort, deserve to know that or embarrassment to reach out . This is valuable insight . We may the patient really does appreciate what you do . want to provide counseling, but how do we reduce the barriers? So, like Tia, take a step around the counter and make yourself How do we overcome both the barrier of being perceived as unap- available and approachable . They will appreciate it . I did . proachable as well as self-imposed barriers by the patient? Thank you, Tia! One way is to simply get out from behind the counter and ask . 1 “Patient perspective of medication information”, JAPhA, July/Aug The other day I was getting some groceries and decided to swing 2011, pp510-519 . by the pharmacy area to see what niacin they had on the shelf . My doctor recently informed me that my HDL/LDL ratio needed

4 Minnesota Pharmacist n Winter 2012 Dear Pharmacy Colleague,

The Minnesota Pharmacists Association is pleased to host the 5th Annual platform/poster presentation program at the MPhA 128th Annual Meeting, Minnesota Research and Practice Innovation Forum being held at Madden’s Resort in Brainerd, Minn . Upcoming Events This venture provides an opportunity for those of us performing research or Visit www.mpha.org developing innovative pharmacy services to present findings and experience to for more information pharmacy practitioners in Minnesota . It is an exciting opportunity for practicing pharmacists, academic faculty, residents and students to display their work, and to share its impact with the individuals responsible for serving the medication needs of Minnesota’s citizens . In past years we have received excellent examples of innovation and research in pharmacy; and we hope that more pharmacists 128th Annual Meeting, and students will participate this year . June 8-10, 2012 The platform presentation program will be held on Saturday, June 9, 2012, Madden’s Resort, Brainerd from 10:00 a .m . to 11:00 a .m . as part of the MPhA continuing pharmacy education . The posters will be displayed in the Exhibit Hall from 12:00 noon HerbIe Cup Golf Invitational, to 1:30 p .m . immediately following the Oral Abstract presentations . June 8, 2012 You are strongly invited/encouraged to submit an abstract of your work using Madden’s Resort, Brainerd the form on page 22 . Please indicate if you prefer platform or poster presentation format on the form . The program has capacity for four platform presenta- Pharmacy Technician tions and 24 posters . The selection committee will make the final determination . Authors should plan a 15-minute platform presentation which includes time for Conference questions . Audio-visual equipment will be available [please check the appropriate MSHP/MPhA Event, boxes on the form for audio-visual needs .] Submission deadline is Friday, April July 19, 2012 22, 2010 . Notification of acceptance and presentation format/time will be sent Crowne Plaza, Plymouth via email to the address provided on the abstract by May 2, 2011 giving abstract presenters time to prepare posters to display for the Annual Meeting . FAll Clinical Symposium, The Minnesota Research and Practice Innovation Forum abstract form September 16, 2012 is attached in Word format, or you can go to the Minnesota Pharmacists Crowne Plaza, Plymouth Association Web site (www .mpha .org) to download the abstract form . If you are unable to access the abstract, we can email, fax, or mail a copy to you . If you have any questions, contact Julie Johnson at the MPhA office at julie@mpha .org fall mtm symposium, or 651-290-7486 . November 16, 2012 DoubleTree Hotel, Bloomington Please encourage students and colleagues working on projects with application to any aspect of pharmacy practice/administration/management to submit an abstract for presentation at the Conference .

Sincerely, Scott Setzepfandt, RPh Moved, graduated, or have a name change? Update your profile MPhA President through your online MPhA Member Portal page.

MinnesotaMinnesota Pharmacist Pharmacist n Winter n Winter 2012 2012 5

executive’s report Remembering The Dream Weaver by Julie K. Johnson, PharmD, MPhA Executive Vice President/CEO

My classmates at the University of Minnesota Class of 1981 Your dreams live on in all of us, Larry . Thank you for the things called him “Dream Weaver .” My memory from College of you gave to us . You have paid it forward for a very long time . Pharmacy days blurs a little — but here is my perception of that time: Classes were challenging . The curriculum seemed to be forever changing . The question of the day was, “should I go on to get Julie K . Johnson, PharmD my PharmD?” Did I mention the classes were challenging? The MPhA Executive Vice President/CEO thought (to me) of spending two more years working/studying/ working/studying/taking tests/working did not appeal to me at all . No one could convince me that more education was going to prepare me to land a better job any faster than I would gradu- ating with a BS in pharmacy in 1981 from one of the highest ranked colleges in the country . I had a plan . Graduate, get out, get a job, don’t look back — and for heaven’s sake, don’t go back . Does this sound at all familiar to anyone? Do things change as much as they stay the same? Larry Weaver led the growth of the profession of pharmacy throughout his entire life . He pushed to improve curricula, build buildings, and move the College of Pharmacy into the health sci- ences complex from its original home in riverside Appleby Hall . I did go back, like many of you . Back to the College of Pharmacy to be a preceptor, to be a mentor, to deliver a lecture and to teach classes . I joined the association after graduation because someone made me . I joined the staff of the College on a part-time basis for 12 years . I joined the MPhA in 2001 . I returned to complete my PharmD in 2006, long after Larry Weaver “retired .” My perceptions changed as years passed . His effect on me, and everyone he knew, was profound . No one person directly influences one other person all on his or her own . But the tapestry of positive influence created by the lifelong contributions of people like Larry Weaver will forever exist . He dreamed big and never, ever, ever gave up . He was dean in the ‘80s and then again later, when he was needed in that position again . WHAT? Who would do that? Nobody is dean twice . He was present at every pharmacy function I can remember . Big as life with his life partner always at his side . Kind, soft spoken, a small-statured giant . Larry was my dean . I did not know what that meant in the ‘80s . I know now .

Minnesota Pharmacist n Winter 2012 7 viewpoint

Walgreens: “America’s premier pharmacy”1 lives up to its self-image

by Lowell J. Anderson, DSc, FAPhA

This is a pat on the back for Walgreens for its public and pro- with independents, where (in Minnesota) there is a whole fessional leadership . generation of pharmacists who have not experienced the thrill of having a PBM increase a dispensing fee . It is not about Express Scripts (ESI) — ESI is just doing what PBMs normally do . As partial justification for its action, Walgreens cites pharmacy services that are currently not compensated . Walgreens has chosen to reject the contract offered by Express Scripts and removed itself from the Express Scripts With growth in prescription-drug sales slowing, Walgreens network by January 1, 2012 . and other major retail pharmacy chains hope to boost revenue by offering new health-care services . In addition to filling I have no idea what the dollars are in the negotiation . It really prescriptions, they now help patients manage their medica- doesn’t matter to me, because it is not so much the why as tions . For example, Walgreens pharmacists advise custom- it is the how . Walgreens effectively told the world that there ers on appropriate doses and try to switch them to cheaper was a reimbursement even they could not accept . They have generic alternatives when possible . managed to save some contracts because of the relationships and contracts with employers . By the time this is printed they “Our product is not a pill; our product is a health outcome,” may have even have come to terms with ESI . says Walgreens Chief Executive Greg Wasson . In the meantime, it will have caused concern or inconve- Express Scripts’ response thus far: A pill’s a pill, and Walgreens nienced a lot of Walgreens customers . But those several mil- doesn’t deserve more money than other pharmacies for telling lions might just get a feel for the economic facts of life in the patients how to take them . If Express Scripts did agree to pay prescription business . The company’s stock is down 30% since more, Walgreens would become its most expensive pharmacy, rais- they announced the disagreement in June . That is a lot of ing client costs “for essentially doing the same thing as everyone money — so even the investor community might understand . else,” says spokesman Brian Henry 2. I know that contrary to conventional wisdom, chains do reject Re-read that Express Script response — it is telling! Mr . contracts for a variety of reasons . We rarely hear of these Henry’s assertion that “A pill’s a pill” clearly reflects a philoso- rejections because it is good business to keep contract nego- phy that a prescription medication is merely a product that tiations close . They usually do not broadcast these decisions requires distribution . Evidently ESI has little corporate concern to either the public or broadly to the profession . about whether or not the “pill” achieves the desired outcome — the outcome that its employer customer is paying for . Pharmacists in independent practice understand that they have little bargaining clout when it comes to negotiating con- On the plus side, Mr . Henry does recognize that “everyone tracts with pharmacy benefit managers and managed-care else” does provide information . Of course they don’t pay organizations . In spite of the often-repeated assertions by “everyone else” either . these organizations that contracts are negotiated, the independents are usually told to “take it or leave it,” should they I imagine that this was a much-researched decision by try to negotiate . More often than not, to “leave it” is not an Walgreens as there are very real costs and market consid- option for the independent and smaller chains . erations . I have no doubt that Walgreens assessment was that signing the offered contract would not be a financially The chains, however, may negotiate with some degree of responsible and defensible decision . Ultimately, they must success because the PBMs and MCOs need their distribution answer to the Walgreens’ stockholders . channels; and one negotiation may result in several thousand outlets . I suspect that many of the chain/PBM contracts have Mr . Wasson, Walgreens CEO, said in an analyst conference even kept pace with the rising costs of dispensing even if not call: “The terms Express Scripts offered us, including rates that fully recovering dispensing costs . Certainly that is not the case were below the industry average cost to provide the prescription,

8 Minnesota Pharmacist n Winter 2012 were not in the best interest of our company, our customers, our of our company, our customers, our employees or our share- employees or our shareholders .”3 holders”? ESI is in a sticky spot here also . If it does agree to a contract Personally, I commend Walgreens for its actions — both for with Walgreens that assigns a value for what “everyone does rejecting a contract that was not in its interests or the inter- for free” it will provide an opportunity for other pharmacy ests of the customers it serves, and even more important, for providers to seek similar treatment that recognizes the value bringing the issue to the professional, public and investor of pharmacists’ services in their next contracts . communities . Corporate courage — sometimes hard to distinguish from tough negotiating, but still courage — is a rarely seen attri- bute today . I think that the pharmacists of America should Lowell J. Anderson, D.Sc., FAPhA, practiced in community pharmacy support the courage of Walgreens . When the Express Script for most of his career. He is a former president of MPhA, Mn Board member transfers a prescription because of this contract of Pharmacy and APhA. In addition he has held positions in the disagreement, the receiving pharmacist should talk to the Accrediting Council on Pharmacy Education, National Association of member about the importance of compensation for valuable Board of Pharmacy and the United States Pharmacopeia. Currently services and compliment Walgreens for its courage . And also he is Co-director of the Center for Leading Healthcare Change, how their employer and its PBM have chosen to not pay for University of Minnesota and co-editor of the International Pharmacy these services . The Walgreens pharmacists, I hope, do likewise Journal. He is a Remington Medalist. when their patients ask about the contract . Walgreens, by some estimates, may lose 10% of prescription volume over this . Are the independents and other chains 1 Walgreens Web site prepared to take a stand with similar costs? Our history is that 2 we do not . And, of course, that is why the fee schedules are “Walgreens seeks payment for customer counseling in Express Scripts what they are . When pharmacy owners and managers read battle”, The Wall Street Journal, 25 October 2011 these contracts it should be with the same question that Mr . 3 Medill Reports, Shaina Humphries, 15 November 2011 Wasson addressed: are these contracts “in the best interest

Minnesota Pharmacist n Winter 2012 9 feature

Drug dosing based on kidney function: a survey of minnesota pharmacists

By Kenzie G. Hohman, PharmD Candidate, and Wendy St. Peter, PharmD, BCPS, FASN, FCCP

Drug dosage adjustment based on kidney func- standardization reduces variation of serum creatinine measurement tion is a standard of practice in some ambula- between laboratories . Although standardization provides more consistent serum creatinine values, the values are slightly lower, tory and most acute care settings as impairment on average, than those before creatinine standardization 10,21. Most of kidney function alters the pharmacokinetics of drugs’ labeling were developed prior to standardized calibration several medications. Dose modifications based on of creatinine assays . This has made assessing kidney function for the purpose of drug dosing adjustment more complex . Thus, it is kidney function are made to improve therapeutic important to determine how pharmacists in Minnesota are assessing outcomes and minimize adverse effects or toxic- kidney function for the purpose of drug dosage adjustment . ity. Direct measurement of the glomerular filtration rate (GFR), using an exogenous marker such as Methods: inulin, is the most accurate method to measure kid- A cross-sectional survey was distributed to pharmacist members of the Minnesota Pharmacists Association (MPhA) and the Minnesota ney function, but is difficult, time-consuming, and Society of Health System Pharmacists (MSHP) . The 13-item ques- expensive.2,12,18 There are several other methods tionnaire was created and administered through a Web-based survey to estimate kidney function and method utilization program, SurveyMonkey . The University of Minnesota institutional review board approved the survey and overall research plan . varies between practitioners.1-3,8,16 This creates a challenge in determining the optimal dosing regi- Members of MPhA were reached through the January CAPS newsletter . MSHP’s members were invited to participate through an men. email sent in December 2010 . The questionnaire addressed the following: equation(s) used to To facilitate in the detection of CKD, the National Kidney Disease estimate kidney function for drug dosage adjustment, body weight Education Program (NKDEP) strongly encourages laboratories to choice for the C-G equation, adjustment of serum creatinine values routinely report estimated GFR values when serum creatinine values based on age, and knowledge of eGFR reporting and serum cre- are measured in patients 18 years or older 11. The availability of the atinine standardization . Demographic information on responding eGFR in laboratory reports may result in confusion among health pharmacists was also collected . professionals on whether or not to use reported eGFR results to dose medications . Up to this point, there have been no prospective pharmacokinetic studies that have utilized eGFR results to create Results: drug dosing recommendations . The survey was sent to a total of 1110 pharmacists, 367 pharma- The U .S . Food and Drug Administration’s (FDA) guidance docu- cists in MSHP and 743 pharmacists in MPhA . 164 pharmacists ment for kidney impairment, published in 1998, recommends that completed the survey for a response rate of 15%; however the num- pharmaceutical companies use the Cockcroft-Gault (C-G) equation ber of dual members is not known, thus the response rate may be to estimate kidney function 5. Thus, most medications’ renal drug higher . dosing guidelines have been developed using the C-G equation as Most of the pharmacists who responded to the survey worked in the the basis for estimating kidney function . A variety of body weights hospital setting and about half of all respondents were under age including actual body weight, ideal body weight, adjusted body 40 . In addition, 68% had a PharmD degree and 41% had residency weight, or lean body weight are utilized for the weight parameter training . within the C-G equation . Also, for serum creatinine values less than 1 mg/dL, some practitioners may round up to 1 mg/dL, or another Most pharmacists used the C-G equation (99%) while only 14% value, depending on patient parameters (i .e . weight or age) . reported using Jelliffe, 13% MDRD, 10% Salazar-Corcoran, and 6% Modified-Jelliffe at some time in their practice setting (Figure To add to the clinical conundrum, the NKDEP has recommended 1) . that creatinine assay manufacturers incorporate assay calibration standards .10,11 To date, the majority of clinical laboratories are Pharmacists reported using a variety of weight parameters and 11 using standardized creatinine assays . Creatinine assay calibration Kidney Function continued on page 11 Kidney Function continued from page 10 Final recommendations have not been published 6. The Nephrology Practice and Research Network of the American College of Clinical adjusting the serum creatinine value in the C-G equation given Pharmacy (ACCP) also recommends estimating kidney function various patient scenarios . A summary of the various methods can using both the C-G equation and an appropriate GFR estimating be found in Figures 2-3 . In obese patients, 86% reported using equation . The re-expressed MDRD or CKD EPI equation should adjusted body weight and 64% reported using ideal body weight, be utilized if the laboratory uses a calibrated serum creatinine assay . either all or some of the time . In non-obese patients, 80% reported If suggested drug dosage adjustments differ based on results from using actual body weight and 82% reported using ideal body each equation, the clinician should consider the clinical scenario, weight, either all or some of the time . Values of serum creatinine evaluate the risk-benefit ratio of potential under- versus overdosing, less than 1 mg/dL were reported to be adjusted to 1 mg/dL (or and use clinical judgment to determine whether the higher or lower another value) by 62% of pharmacists . Of the pharmacists who dose may be more appropriate as the initial dose in that individual adjust serum creatinine values when the reported value is less than patient 13. 1 mg/dL, 53% reported making this adjustment at a certain age cutoff . A variety of age cutoffs were reported with age 65 appearing There was significant variability in the choice of weight used most frequently . in the C-G equation (i .e . ideal versus actual or adjusted body weight) . Based on our survey, Minnesota pharmacists are 58% of pharmacists were unsure if their institution was utiliz- consistent in that few pharmacists use actual body weight for ing a standardized serum creatinine assay . 86% of pharmacists obese patients . Results were much more variable between the were aware of their institution’s reporting of automated eGFRs; use of adjusted body weight and ideal body weight in obese 75% of pharmacists indicated their institution did report and patients . Similarly, for non-obese patients, only 2% reported 11% indicated their institution did not report eGFR values . always using adjusted body weight but many pharmacists used actual or ideal body weight . Use of various weight parameters in the C-G equation increases the variability in Discussion: results from one practice to another . Providing optimal medication therapy is often dependent upon estimating a patient’s kidney function . Overestimating A recent article by Pai reviews the most appropriate weight param- kidney function may result in drug toxicity, while underesti- eters to use in obese patients when using C-G or eGFR equations, mating kidney function may lead to subtherapeutic dosing such as MDRD or CKD-EPI . Evidence supports use of total body and treatment failure . weight (aka actual body weight) in the C-G equation unless the patient is obese (BMI >30) . In obese patients, lean body weight Several equations exist to determine drug dosing in patients with (LBW2005-Figure 4) is a better weight parameter to use than impaired kidney function; however, none of the equations are per- ideal body weight . For eGFR equations, multiply the eGFR by the fect . The C-G equation was developed in 1976 to estimate CrCl patient’s BSA, using the Mosteller BSA method (Figure 4) 14. Of and is used as a rough estimate of GFR 2. The majority of kidney note, using the Mostellar BSA adjustment method can greatly over- drug dosage adjustments have been determined using CrCl and the estimate eGFR in morbidly obese patients . The ACCP Nephrology C-G equation as the standard . The MDRD 4-variable equation Practice and Research Network also supports use of lean body was originally developed in 1999 . It has been shown to be more weight in the C-G equation for obese patients 13. Unfortunately, accurate than the C-G in estimating GFR 8,11. However, it is not our survey did not specifically query about the use of lean body very accurate in individuals with a GFR > 60 mL/min/1 .73m2 . weight in the C-G equation in obese patients . The MDRD 4-variable equation was re-expressed for use with standardized serum creatinine values . The newer CKD-EPI equation In 2005, the NKDEP initiated a creatinine standardization pro- was developed for use with standardized serum creatinine and is gram to reduce interlaboratory variation in creatinine assay calibra- more accurate than the MDRD equation in patients with GFR>60 tion .11,19 Prior to creatinine standardization, variation in creatinine mL/min/1 .73m2 . The C-G equation cannot be re-expressed for assays resulted in inconsistent creatinine values and thus potentially standardized creatinine because the creatinine method used in the inconsistent drug dosing recommendations . Most clinical labo- development of the equation is no longer in use and samples from ratories are now utilizing creatinine assays that have calibration the study are no longer available 12. All of these equations are lim- traceable to an isotope dilution mass spectrometry (IDMS) refer- ited by the use of creatinine as a filtration marker . The serum level ence . Assay calibration yields more consistent but slightly lower of creatinine is determined by factors other than the GFR, such as serum creatinine values, on average, than the values yielded prior to kidney tubular secretion, diet, and muscle mass . The MDRD and implementation of standardized creatinine 21. Lower serum creati- CKD-EPI equations more accurately estimate GFR than C-G and nine values result in a higher eCrCl calculation that may result in are used to stage chronic kidney disease 11. However, as noted previ- a higher recommended dose as compared to the timeframe before ously, most dosing recommendations were not based on measured creatinine standardization . A majority of Minnesota pharmacists, or estimated GFR but rather estimated CrCl 5. approximately 58%, were unaware of whether or not serum creatinine values from their clinical laboratory were standardized . More Based on our survey results, C-G was the equation predominantly education is needed, as pharmacists should understand the implica- used by Minnesota pharmacists for drug dosage adjustment in tions of using standardized creatinine values . patients with kidney dysfunction . Use of the C-G equation is consistent with the FDA’s current recommendation for pharmaceutical companies 5. However, the FDA has recently issued an updated draft guidance document for kidney impairment that Kidney Function continued on page 12 recommends use of both MDRD for eGFR and C-G for eCrCl .

Minnesota Pharmacist n Winter 2012 11 Kidney Function continued from page 11

Conclusions: Figure 4: Weight Parameter Adjustments for use in Estimating Appropriately assessing kidney function is imperative to prop- CrCl and GFR for Drug Dosage Adjustment in Obese Patients erly dose drugs eliminated by the kidneys . The C-G equation is predominantly used by Minnesota pharmacists to estimate kidney function for drug dosing purposes . But creatinine assay standardization presents additional challenges when interpreting C-G results . Pharmacists need to understand the implications of standardized creatinine values and weight parameters on the variability of CrCl results when using C-G for drug dosing in patients with reduced kidney function, especially with narrow therapeutic index drugs and in critically ill patients . A standardized approach to drug dosage adjustment in patients with stable kidney function, as suggested by the ACCP Nephrology Practice Research Network, will help reduce variability in drug dosing adjustments from one practice to another . References: 1 Bouchard J, Macedo E, Soroko S, et al . Comparisons of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury . Nephrol Dial Transplant . 2010; 25:102-107 .

2 Cockcroft DW, Gault MH . Prediction of creatinine clearance from serum creatinine . Nephron . 1976; 16:31-41 .

3 Demirovic JA, Pai AB, Pai MP . Estimation of creatinine clearance in morbidly obese patients . Am J Health-Syst Pharm . 2009; 66:642-648 .

4 Dowling T, Matzke G, Murphy J, Burckart G . Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches . Pharmacotherapy . 2010; 30(8):776-786 .

5 Food and Drug Administration . Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing and Labeling. Department of Health and Human Services; May 1998 . http://www .fda .gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm064982 .htm .

6 Food and Drug Administration . Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing and Labeling (Draft Guidance) . Department of Health and Human Services; March 2010 . http://www .fda .gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm064982 .htm .

7 Hermsen ED, Maiefski M, Florescu MC, et al . Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Dosing Antimicrobials . Pharmacotherapy . 2009; 29(6):649-655 .

8 Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation . Ann Intern Med . 1999; 130:461-70 .

9 Moranville M, Jennings H . Implications of using modification of diet in renal disease versus Cockcroft-Gault equations for renal dosing adjustments . Am J Health-Syst Pharm . 2009; 66(2):154-161 .

10 Myers G, Miller WG, Coresh J, et al . Recommendations for improv- ing serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program . Clin Chem . 2006; 52(1):5-18 .

Kidney Function continued on page 15

12 Minnesota Pharmacist n Winter 2012 4Fraud and Abuse Training 4Pseudoephedrine Log 4OSHA Requirements 4HIPAA Privacy and Security Policies and Procedures Quality Assurance (QA) Program

Is a QA Program Missing From Your Checklist? Pharmacy Quality Commitment™ (PQC™) is what you need! Reduction of medication errors and implementation of a QA program are no longer options. A growing number of pharmacy network contracts require a process in place and no matter what it is called, QA, CQI, safe medication practices, or medication error identification and reduction program – PQC™ is the answer.

The PQC™ Program: • Legally protects reported data through a federally listed Patient Safety Organization (PSO) • Helps increase efficiency and improve patient safety through a continuous quality improvement (CQI) process • Provides easy-to-use tools to collect and analyze medication near miss and error data • Presents a turnkey program to help you meet obligations for QA and CQI requirements • Includes simple method to verify compliance • Offers excellent training, customer service and ongoing support

Not all programs are the same, make sure your pharmacy and your data is protected. Pharmacies that license PQC™ and report patient safety events are provided federal legal protection to information that is reported through the Alliance for Patient Medication Safety (APMS) – a federally listed PSO. To learn more about PSOs, visit www.pso.ahrq-gov/psos/fastfacts.htm.

TM Call toll free (866) 365-7472 or go to www.pqc.net for more information.

PQC is brought to you by your state pharmacy association.

Minnesota Pharmacist n Winter 2012 13 feature MN PhARMACY Minnesota Practice-Based Research Network: An Update

By Rita Tonkinson

Minnesota’s pharmacy prac- to investigate questions related to community based practice .” tice-based research network (PBRN) was introduced about During the last few months of 2007, the Minnesota Pharmacists five years ago to pharmacists Association (MPhA) and the University of Minnesota College of PRACTICE BASED in the November/December Pharmacy developed a Minnesota Pharmacy PBRN, introducing RESEARCH NETWORK 2007 issue of the Minnesota the concept at MPhA’s Pharmacy Nights that fall . At that time, Pharmacist . It was formally 30 pharmacies were enrolled . In order to be considered a PBRN launched in February 2008 . Since the initial article, little has been by national funding agencies, at least 15 practice sites are required . reported in this publication . It’s time to focus attention on the Beginning in March of 2009, grant proposals were submitted for progress of the network, and encourage Minnesota’s pharmacists to funding . Requirements for consideration by a funding agency review the programs, take a look at the opportunities, and consider included in the grant competitions are: 1) a “network capacity” the options . consisting of pharmacies willing and able to collaborate on projects and 2) an infrastructure for managing the projects . The PBRN was announced by Jon Schommer, PhD, RPh, professor, University of Minnesota College of Pharmacy, in the above The two organizations have developed a PBRN “Capacity mentioned article . A few Minnesota Pharmacist readers may not Portfolio,” a document for internal use and to be submitted to recall the article; others may have lost track of the network’s prog- funding agencies as part of Minnesota PBRN proposals . This is ress . Following is a brief history, followed by an update . Much a dynamic document, expanding to reflect the developing PBRN of this recap is taken from Schommer’s 2007 article and from network . the white paper written in May 2010 with Schommer as the lead The building blocks of a PBRN included a sponsoring organi- author . The white paper was also supported by a distinguished zation, community pharmacy residency program accreditation advisory/review board of pharmacists, national association lead- requirements in place and the development of technology stan- ers and academic pharmacy leaders . The paper “Establishing dards . In his paper, Schommer described results of a survey of the Pharmacists Practice-Based Research Network, an American Community Pharmacy Residency Program members (November Pharmacists Association (APhA) Foundation White Paper,” 2009) that revealed some barriers to securing finding for conduct- describes the process of looking at more than “two decades of suc- ing practice-based research . These perceived barriers included access cess for PBRNs in primary care practice and the coincident evolu- to electronic medical records and lack of resources/time, and experi- tion of community pharmacy practice as a recognized patient access ence of securing funding . The next step was developing an infra- point .” In the paper, Schommer cites the point that medications are structure: 1) director, 2) coordinator, 3) one-way communication, used by almost all members of society and pharmacists are accessi- 4) two-way communication, 5) membership roster, 6) meetings, 7) ble providers of medications to the public . The paper clearly defines board, and 8) human subjects’ protection management . Schommer the process leading up to the launch in Minnesota . also described other infrastructure elements that might be necessary, In the Executive Summary, Schommer described what he called a such as 1) research assistants, 2) information technology, 3) regula- “Research Gap Analysis .” He said that “leaders within the APhA tory compliance, or 4) research consulting expertise . Community Pharmacy Residency Program (CPRP) began discus- To this end, PBRNs can use an academic institution’s resources sions regarding the creation of a Practice-Based Research Network already in place as partners, where research, grant writing, data using CPRP sites (named PBRNet) . To begin dialogue for this management, one- and two-way communications and other exper- idea, 15 individuals who were affiliated with community pharmacy tise are available . The ultimate goal, of course, is to translate the residency programs convened to participate in a focus group on research findings into practice, i .e . enhance patient care and under- April 5, 2009 in San Antonio, Texas . The purpose of this inquiry score the importance of accessibility to pharmacists’ care . was to understand the most important elements needed for an infrastructure to support a PBRNet .” The Minnesota Pharmacists Association reported that as of December 2009, 305 pharmacy practice locations were part of the To understand the scope of a PBRN, the nationally accepted defi- Minnesota PBRN . Among those practice sites were: 1) community- nition of a practice-based research network is helpful . Schommer based pharmacies, 2) hospital-based pharmacies, 3) community- describes a PBRN as “a group of ambulatory practices devoted based clinics, and 4) one investigational drug service (not available principally to the primary care of patients, affiliated with each other to the general public) . All but six of the PBRN pharmacies dispense (and often with an academic or professional organization) in order PBRN Update continued on page 15

14 Minnesota Pharmacist n Winter 2012 PBRN Update continued from page 14 Kidney Function continued from page 12 medication to the public . An array of PBRN research collabora- tions can include, but are not limited to, patient screening, edu- 11 National Kidney Disease Education Program . Laboratory Professionals: cation, referral, continuity of care, and follow-up as well as drug Creatinine Standardization and Estimating & Reporting GFR . Available regimen review, patient outcomes and data retrieval . online at: http://www .nkdep .nih .gov .floyd .lib .umn .edu/labprofessionals/ index .htm . In its ongoing role as a valuable resource for its members and for the public, MPhA has further enhanced its role in disseminating 12 National Kidney Disease Education Program . Chronic Kidney Disease PBRN network information on its Web site and through other and Drug Dosing: Information for Providers (Revised January 2010) . communications with its members . Julie K . Johnson, PharmD, Available online at: http://www .nkdep .nih .gov/professionals/drug-dos- executive vice president and CEO, MPhA, served in an advisory ing-information .htm . capacity in the beginning of the PBRN program and continues 13 Nyman HA, Dowling TC, et al . Use of the Cockcroft-Gault ver- to serve in various ways as the network continues to develop . If sus MDRD Study Equation to Dose Medications: An Opinion of the you wish to view the current list of PBRN projects and locate the Nephrology Practice and Research Network of the American College of map of PBRN locations, visit: http://www .mpha .org/associa- Clinical Pharmacy . Pharmacotherapy . 2011 . tions/9746/files/PBRN/index .html . 14 Pai MP . Estimating the glomerular filtration rate in obese adult “Dr . Schommer has called participating in such a network as col- patients for drug dosing . Advances in Chronic Kidney Disease . 2010; lecting information in real-world settings to help address societal, 17(5): e53-e62 . community, or professional questions that relate to medication use,” said Johnson . “Based on feedback from individual pharma- 15 Prigent A . Monitoring renal function and limitations of renal func- cists involved in the PBRN, while continuing to provide expand- tion tests . Semin Nucl Med . 2008; 38(1):32-46 . ed patient services and promote the value of pharmacists in the 16 health care community, many have said they have enhanced their Salazar DE, Corcoran GB . Predicting creatinine clearance and renal professional and personal experience .” drug clearance in obese patients from estimated fat-free body mass . Am J Med . 1988; 84:1053-60 . During 2011, Schommer said in a communication on the status 17 of PBRN, there were ongoing preparations for funding proj- Siew E, Matheny M, Ikizler TA, et al . Commonly used surrogates ect proposals . There is also a listing of papers covering current for baseline renal function affect the classification and prognosis of acute practice-based research on the College of Pharmacy Web site, kidney injury . Kidney Int . 2010; 77(6):536-42 . Innovations in Pharmacy . Visit this site for additional important 18 Stevens L, Nolin T, Richardson M, et al . Comparison of drug dosing information: http://www .pharmacy .umn .edu/innovations/pbre- recommendations based on measured GFR and kidney function estimat- search/home html ing equations . Am J Kidney Dis. 2009; 54(1):33-42 .

In the same communication Schommer described goals for 2012: 19 Stevens L, Stoycheff N . Standardization of serum creatinine and “Our goals for 2012 are to continue preparing project proposals estimated GFR in the Kidney Early Evaluation Program (KEEP) . Am J and to complete funded projects . We are nearing the point in our Kidney Dis . 2008; 51(4):S77-S82 . development as a PBRN where we can discuss the types of projects for which we have achieved the greatest success and consider 20 Verbeeck RK, Musuamba FT . Pharmacokinetic and dosage adjust- ways to invest in those areas . Our PBRN is beginning to establish ment in patients with renal dysfunction . Eur J Clin Pharmacol . 2009; an identity, and we can consider ways to build upon that foun- 65:757-773 . dation . One challenge is to anticipate how our capabilities and 21 Wade W, Spruill W . New serum creatinine assay standardization: capacities can fit into the opportunities that are still emerging .” implications for drug dosing . Ann Pharmacother. 2007; 41(3):475-480 . As of February 2012, the Minnesota PBRN consisted of 366 geographically dispersed pharmacies and 23 principal investiga- tors from the University of Minnesota (See Appendix D of Dr . Schommer’s most recent summary on MPhA’s Web site) . A summary of projects that have utilized the Minnesota Pharmacy PBRN can be found in Appendix E of the same document entitled, “The Minnesota Pharmacy Practice-Based Research Network .” Review the complete text of the white paper, “Establishing Pharmacists Practice-Based Research Network, an American Pharmacist Association Foundation White Paper,” by following the link: http://www .pharmacist .com/AM/Template . cfm?Section=Professional_Advancement&Template=/CM/ ContentDispaly .cfm&ContenID=23805

Rita Tonkinson is a contracted staff writer for the association, who provides insightful looks into the field of pharmacy for our readers. Minnesota Pharmacist n Winter 2012 15 PHARMACY MARKETING GROUP, INC. • PHARMACY and the law

recordkeeping isn’t that important, is it?

by Don McGuire, RPh, JD

This series, Pharmacy and the Law, is presented by Pharmacists comes to acquisition Mutual Insurance Company and your State Pharmacy Association cost or reimbursement In litigation, documentation through Pharmacy Marketing Group, Inc., a company dedicated to rates . One may have providing quality products and services to the pharmacy community. been non-formulary, is everything. If it wasn’t for example . This dif- Terry at Midtown Pharmacy was dealing with another recurring ference is multiplied if documented, it wasn’t frustration . The pharmacy’s usual generic brand of atenolol was one product is the brand backordered again . Terry ordered a couple of 100 count bottles name one . Clinically, done. Many cases have to hold them over until the usual brand was available again . Terry none of the differences didn’t bother to update the computer database to reflect this are significant . However, turned on seemingly small change because she would then just have to change it back again we aren’t talking about two days from now . The change isn’t really that important any- therapeutics . We are documentation issues. way, right? talking finances and Wrong . Your documentation is the only thing you will have recordkeeping . This sort later to prove what you did today . We all forget things, espe- of discrepancy can lead to repayment demands, even penalties and cially when they come up weeks or months later . Consider the interest, following an audit . following claim scenario . The importance of recordkeeping shouldn’t be overlooked . A pharmacy was sued by a former patient over some faulty In litigation, documentation is everything . If it wasn’t docu- transdermal fentanyl patches . The patient alleged that he was mented, it wasn’t done . Many cases have turned on seem- injured due to the patch releasing the medication too quickly . ingly small documentation issues . Perpetual inventory totals, The patient’s profile indicated that he received the patch timecards, delivery records, pick-up logs, documentation of manufactured by company A . Company A’s product had, in counseling (or refusal of counseling) are some other examples fact, been recalled due to this very problem . The patient was of records that have become key points in a case . The lesson sure that the excessive dose delivered had caused him to here is that no record is too small or too trivial to be skipped be hospitalized . The pharmacy staff went through months over . Update those inventory changes as they come in . It may of anxiety and expense while producing records and being seem burdensome at the time, but there are potential ben- deposed . What everyone learned at the end was that the efits later . patch received by the patient wasn’t manufactured by company A . He had received patches manufactured by company B . This was discovered when reviewing the invoices from the time period in question . Company B’s product had been © Don R. McGuire Jr., RPh, JD, is General Counsel at Pharmacists purchased because of the recall of company A’s patches . Mutual Insurance Company. However, the patient profile indicated that the patient had This article discusses general principles of law and risk manage- received Company A’s patches . Proper recordkeeping would ment. It is not intended as legal advice. Pharmacists should consult most likely have prevented this pharmacy from suffering their own attorneys and insurance companies for specific advice. through months of litigation . Pharmacists should be familiar with policies and procedures of their A second consideration here is billing . In today’s world, it is employers and insurance companies, and act accordingly. more important than ever to bill for what was actually dispensed . Third-party payers expect and demand that their customers receive the product that is billed to the third-party payer . While the two different fentanyl patches discussed above may be clinically interchangeable, they are probably not the same when it

16 Minnesota Pharmacist n Winter 2012 A Buying group for independent retAil phArmAcies

...owned by 19 state pharmacy organizations ...a leader negotiating on behalf of independents ...saving pharmacies money for more than 25 years ...financially supports the state pharmacy organizations ...serving pharmacies nationwide

1-888-200-0998 | www.pacealliance.com

Minnesota Pharmacist n Winter 2012 17 Student Perspective Home care: A new frontier for pharmacy practice

Delford Ilara Doherty, PharmD and MPH Candidate, 2010; University of Minnesota College of Pharmacy and School of Public Health

With millions of baby boomers retiring and turning to Medicare when prescribers lack knowledge of the patient’s complete medica- for their health insurance needs, many in the health care industry tion regimen or don’t understand how medications are used in are looking to combat rising health care costs in order to sustain the home . Home health care providers also often deal with low this program . Pharmacists are well-trained and well-positioned to reimbursement rates . New practitioners facing record student loan play an integral role in Medicare cost containment . The model repayments may find this a serious obstacle . for pharmacist involvement in health care already exists in current programs such as medication therapy management (MTM) . The However, it’s too soon to dismiss home health care-based MTM . most promising frontier for pharmacists in the rapidly changing The passage of health care reform and emphasis on preventative health care landscape is home health care-based MTM . care are likely to open up exciting possibilities for pharmacy practice . I believe home care will emerge as a leading practice in pro- A valuable opportunity viding preventative care to America’s aging population . For some time, pharmacists have ceded home health care to public This is an opportune time for new practitioners to use ingenuity health nurses who provide services to patients in their homes . My to position themselves for this emerging practice in settings such as first experience with home care MTM came on my ambulatory home infusion clinics, long-term care facilities, MTM clinics, and care rotation with Shannon Reidt, PharmD, MPH, BCPS, at the others . Pharmacists should also consider developing models and Minnesota Visiting Nurse Agency in Minneapolis . Before this mechanisms to partner with home care providers, managed care rotation, I had a vague perspective of home care as the territory of organizations, insurance agencies, and private and public health nurses and public health practitioners . It soon became clear to me, systems . however, that home care-based MTM is a public health necessity and one that presents a great opportunity for pharmacists . Determining patient needs The population of homebound seniors is growing as older patients There is a pressing need for pharmacists to practice home care- attempt to avoid the cost of nursing home institutionalization . based MTM . Being in a patient’s home offers the home care Homebound patients are missed opportunities for clinical interac- pharmacist the opportunity to evaluate the entirety of the patient’s tion . They often have complex medical histories, take multiple circumstances, allowing for a holistic assessment of clinical needs medications, have multiple prescribers, use multiple pharmacies, while considering the physical, functional, and environmental have mobility problems, and lack easy access to pharmacies and factors affecting the patient’s health . Home care pharmacists also clinics that provide MTM services . These patients would greatly have access to all medications, herbal products, and OTC products benefit from MTM services, especially when delivered in conjunc- the patient is using, as well as to caregivers who can offer their tion with a home care agency team . own perspective . This kind of in-depth evaluation could not be accomplished in the clinical setting and produces superior results, Home care has largely been provided by family care providers, which may prove to be the most valuable aspect of home health home care nurses, and other professionals who are not primarily care-based MTM services . trained to identify, rectify, and prevent drug therapy problems . This is a disservice to home care patients with many ramifications, Home health care is a new frontier for pharmacists that makes it including the burden of illness, quality-of-life issues, and substan- possible for them to influence the lives of patients by preventing tial cost to both patients and taxpayers . disease burdens and the costs associated with drug therapy problems . Current and future practitioners should consider the pos- Pharmacy has the opportunity to correct this problem . The phar- sibility of a career in home care-based MTM, which could take the macy workforce is expanding rapidly and ingenuity, especially on form of patient care, consultation, policy, or regulation . Because the part of recent graduates, will soon be a deciding factor in phar- of the changing health care delivery landscape, home care-based macists’ careers . It is imperative for new practitioners to consider MTM is a moral and professional imperative . opportunities in home health care .

Don’t let barriers obstruct patient care The greatest impediment to home care practice is reimbursement . Del Doherty is a fourth-year PharmD & MPH candidate at the Current home health care practitioners often must spend extensive University of Minnesota College of Pharmacy. time coordinating patient care with multiple providers, especially

18 Minnesota Pharmacist n Winter 2012 MPhA Staff

Amanda Ewald, Vice President, Finance and Chris Swanson, Member Service Director. Chris Accounting. Amanda oversees all of MPhA’s finan- helps with events, membership and other projects . cial activities including development of monthly She is one of the friendly people who answer ques- financial statement, paying bills, etc . tions when people call the MPhA office . Email: amandae@ewald .com Email: chriss@ewald .com

Anna Wrisky, Communication Specialist. Anna is David Ewald, President. David helps Julie responsible for producing MPhA’s communications Johnson’s endeavors as appropriate to help main- including CAPS, e-News and the Minnesota tain a strong relationship between staff and the Pharmacist journal and manages the MPhA Web site . organization, and to provide assistance in seeing Email: annaw@ewald .com that MPhA continues to make progress toward its mission . Email: davide@ewald .com

Jacquie Jaskowiak, Assistant Account Executive. Jacquie assists Julie with some of the day-to-day operational activities, and takes a strong role in membership recruitment and retention efforts . Email: jacquiej@ewald .com Stay

Bill Monn, Vice President, Member Services and Connected Marketing . Bill’s responsibilities include supervising the member services department, contract management and assuring appropriate resource and service levels . Bill also works with staff members and Find us on Facebook and LinkedIn. at times directly with clients to develop strategic business plans that promote successful and profitable operations for Minnesota Pharmacists Association client organizations . Email: billm@ewald .com

Kathie Pugaczewski, Vice President, Communication and Technology. Kathie is responsible for supervising the management of communication, Web sites, webinars, developing social media strategy and managing technology operations . Email: kathiep@ewald .com

Kelly Sprague, Meeting Planner. Kelly is responsible for assisting in the excellent execution of MPhA’s education programs . Email: kellys@ewald .com

Laurie Pumper, Communication Director. Laurie works with the MPhA Editorial Advisory Board to develop content for the association’s journal and other communication vehicles, and she assists in providing marketing support for advertising . Email: lauriep@ewald .com Minnesota Pharmacist n Winter 2012 19 MPha board of directors and volunteers

The Minnesota Pharmacists Association is comprised of many important areas that affect mpha 2011/2012 the association as a whole . Some of these board of directors areas are elected positions (board of directors), and others are by appointment or volunteer Executive/finance BOARD MEMBERS AT LARGE (committees, task forces, etc .) . All members of Committee Tim Cernohous (term ends in 2013) PRESIDENT: University of Minnesota - Duluth MPhA are eligible to run for an elected posi- Scott Setzepfandt Business Phone: 218-726-6005 tion or participate in other areas as represen- Genentech cern0037@umn .edu tatives of their setting, academy or district . Business Phone: 952-469-5452 setzepfandt .scott@gene .com Tiffany Elton (term ends in 2012) board of directors Min-No-Aya-Win Clinic Pharmacy The MPhA Board of Directors (BOD) is PAST PRESIDENT: Business Phone: 218-878-2154 Brent J . Thompson tiffanyelton@fdlrez .com comprised of elected officers and representa- FirstLight Health System tives who represent all pharmacy practice Business Phone: 320-225-3595 Amy Sapola (term ends in 2013) settings and geographic regions in Minnesota . bthompson@fl .hs .org Mayo Clinic Sapola .Amy@mayo .edu The Minnesota Pharmacy Student Alliance PRESIDENT-ELECT: (MPSA), the University of Minnesota College Martin Erickson Jill Strykowski (term ends in 2013) of Pharmacy, and the Minnesota Society of Gallipot, Inc . Allina Hospitals and Clinics Health-System Pharmacists (MSHP) also Business Phone: 651-389-0906 Business Phone: 763-236-4137 jill .strykowski@allina .com sit on the MPhA board as representatives of maerickson3rd@gmail .com Jason Varin (term ends in 2013) their respective pharmacy organizations . The SECRETARY-TREASURER: Cub Pharmacy - Chanhassen board meets bi-monthly, and is responsible William Diers Business Phone: 952-934-2865 for reviewing and revising the MPhA strategic United Hospitals - Inpatient vari0001@umn .edu plan and incorporating resolutions passed by Business Phone: 651-241-8851 the MPhA House of Delegates . billdiers@comcast .net SPEAKER: student representation Elections for open board positions occur Minneapolis Meghan Kelly MPSA Student Liaison: annually, with a swearing-in ceremony at the kelly476@umn .edu conclusion of each MPhA Annual Meeting . Kandace Schuft If you are interested in running for a board EXECUTIVE VICE PRESIDENT: schuf007@umn .edu (Ex-Officio): Julie K . Johnson position, please contact Julie Johnson at the DULUTH Minnesota Pharmacists Association MPSA Student Liaison: MPhA office . Business Phone: 651-290-7486 julie@mpha .org Jeremy LeBlanc House of Delegates lebla066@d .umn .edu The House of Delegates (HOD) reviews recommendations and policies to go before the RURAL BOARD MEMBERs Eric Slindee (term ends in 2013) Ex-Officio Board of Directors, and is comprised of dele- Witt’s Pharmacy Rod Carter, COP gates from each of MPhA’s districts and acad- Business Phone: 507-886-2322 U of M College of Pharmacy emies for a full representation of pharmacy in slindee@harmonytel .net Business Phone: 612-625-1135 Minnesota . The largest HOD meeting is held carte068@umn .edu Mark Trumm (term ends in 2012) each June during the MPhA Annual Meeting . Trumm Drug Julie K . Johnson, MPhA Minnesota Pharmacists Association Any MPhA member may volunteer to be Business Phone: 320-763-3111 mtrumm@trummdrug .com Business Phone: 651-290-7486 a district/academy delegate for the HOD . julie@mpha .org Individual district and academy chairs will METRO BOARD MEMBERs determine the amount of delegate reim- Pharmacy technician rep. bursement . If you are interested in being a Cheng Lo (term ends in 2013) Phalen Family Pharmacy Barb Stodola delegate, please contact your chair or Julie Business Phone: 651-209-9000 stodolab@aol .com Johnson at the MPhA office . chenglo11@gmail .com academies James Marttila (term ends 2012) MPhA recognizes the diverse areas of practice Mayo Clinic in Minnesota . Academies allow members in Business Phone: (507)284-8243 the same practice setting to interact and dis- marttila .james@mayo .edu

20 Minnesota Pharmacist n Winter 2012 cuss issues important to their field . Each academy reports to the BOD for any action needing support, as well as the HOD . Current MPhA Academies include: • ACADEMIC • CHAIN MANAGEMENT • COMMUNITY spring • HOSPITAL • INDEPENDENT OWNER pharmacy • INDUSTRY • LONG TERM CARE nights • MANAGED CARE • medication therapy management • Technician Save the date! Each academy is appointed one delegate at HOD meetings, with one additional delegate per every additional 50 members April 5 • Twin Cities in the academy . Each academy chair is responsible for setting meetings and agendas April 12 • Duluth for the academy’s members . New academy chairs are elected each odd year by the members of the academy . April 19 • Rochester Members may choose to participate in multiple academies for a April 26 • Alexandria nominal fee, but may only serve as a delegate for any one academy or district per HOD meeting . Contact Julie Johnson at the MPhA May 9 • Brainerd office for more information on academies . districts May 10 • Bemidji

committees and task forces In order to address pharmacy issues on multiple levels, MPhA has designated committees and task forces to review and recommend action to the BOD . For more information on current committee and task force opportunities, see the volunteer form on the next page . • Public affairs and policy development • professional affairs • awards • community pharmacy business • educational advisory Minnesota is divided into seven districts to allow members in each district to network and discuss regional news and practice ideas . • Editorial Advisory Board Each district reports to the BOD for any action needing support as well as the HOD . Each district has three delegates on the HOD, with one additional delegate for every additional 100 members in the district . Each district chair is responsible for setting meetings and agendas for their members . New chairs are elected each odd year by the members of the district . Some districts take advantage of local Pharmacy Night meetings to gather and discuss district business, including the election of officers .

Minnesota Pharmacist n Winter 2012 21 mpha committees and task forces

the power behind the association The Minnesota Pharmacists Association’s committees and task forces address pharmacy issues on every level . Members of all practice settings (including technicians and students) are needed to provide valuable insight and feedback on the workings and advancement of the association . To become active in a committee or task force, submit the interest form located below, or contact the MPhA office for more details . MPhA’s committees and task forces guide the association, making it as successful as it is today!

Public Affairs & Policy development committee Educational Advisory committee Actively engage in grassroots efforts to pursue MPhA initiatives, Review and suggest educational opportunities for members that monitor and react to state and federal legislation and policies . will allow them to grow and stay current with changes in the Review and recommend new business for the MPhA Board of field . Meets 3x/Year . Committee members will participate in one of Directors and House of Delegates . Meets 10x/Year . the three planning subgroups as a non-committee member: Annual Meeting, Fall Clinical Symposium, Midwinter, Technican Summit, professional affairs committee or Technician Conference. Define and review the pharmacist’s role in the medical home . Review health care reforms, pharmacy practice act, dispensing Editorial Advisory Board compensation, and pharmacy services . Address issues related to the Suggest ideas for articles and/or authors . If willing, advisory board pharmacist’s scope of practice and the advancement of pharmacy . members might write articles for the journal . Meetings are held Meets 10x/Year . at the MPhA office . Meetings typically last two hours or less . Members may use the conference call option . Meets 4x/Year . Awards committee Review and recommend changes to the MPhA award system . This includes changes in criteria or the creation of new awards . Review nomination forms and select award recipients . Meets 2x/Year .

Community Pharmacy Business committee Identify and pursue initiatives to improve the community pharmacy business climate . Support pharmacy business education in economic strategies . Develop materials to help pharmacists with provider issues . Meets 10x/Year .

Committee/task force volunteer application The Minnesota Pharmacists Association relies on its members and pharmacy professionals to lend their time Support the role and insight to our committees and task forces to make them successful components of our profession . The association is continually seeking pharmacists, students, technicians and other pharmacy professionals to of pharmacists become involved and be active in promoting and supporting the work of the association and making pharmacy in Minnesota a profession worth fighting for . in the field and We welcome your interest in serving on one of the above committees or task forces . Please submit this form by the association. fax or mail to the MPhA office . Sign up today and join your peers to take an active role in the perception of YOU can make pharmacy in Minnesota! a difference! YES! I would like to serve on the following committee/task force: ______

Name: ______Organization:______Address: ______City: ______Zip: ______Phone: ______Fax: ______Email: ______

22 Minnesota Pharmacist n Winter 2012 association benefits

The Minnesota Pharmacists Association’s number one priority Products and Services is its members . MPhA strives to provide services and benefits to Members benefit from discounted rates and prices on both our members that not only promote the profession of pharmacy professional and business related services . in Minnesota, but the professional lives of our members as well . Professional Services Ranging from advocacy and communication to discounted • Pharmacists Letter professional and business programs, we are always on the search • Pharmacists Mutual Insurance for benefits that are valuable to you as pharmacy professionals . • Technician Manuals Many of our benefits can be accessed easily through our Web Business Services site . From online dues renewal, conference registration and mem- • Coupon Redemption Program ber searches, we strive to not only make membership valuable, • PAAS 3rd-Party Audit Services but easy to use and navigate . Not able to find what you are look- • Credit Card Processing Services ing for? Contact our office and we can help point you in the right • Pharmacists Financial Service direction . • Discounted AAA Automotive Membership To access your online member benefits, use your email and personal password to login . Your MPhA Member Portal page will Communication allow you quick access to view your current contact information, Communication is our cornerstone of keeping you informed of registered events, and invoice statements . If you forget your pass- association, state and national news and action . word, use the password link to have it reset through your email Minnesota Pharmacist account . Still having problems? Give us a call to confirm we have The Minnesota Pharmacist is the association’s quarterly journal the correct email on file . that contains articles and features on today’s pharmacy topics, Membership Dues: and mails to all MPhA members . Check with your employer to see if they cover a portion of MPhA CAPS membership. Membership dues can be renewed online and a por- CAPS is our monthly faxed/emailed newsletter that keeps phar- tion of your dues is tax deductible (consult your tax adviser with macy professionals abreast of timely pharmacy issues and happen- questions) . We offer a variety of options to make payment more ings . The newsletter is faxed to all pharmacies in the state, and is convenient, including a monthly debit program that will debit emailed to all MPhA members . your credit card, checking or savings account each month (call the MPhA office to set up this feature) . E-News E-News is our email newsletter that goes out to all subscribed advocacy members . Monthly e-news shares upcoming events and topics, MPhA works to provide members with a “voice” in pharmacy while single e-news items may alert you to important legislative at the state and national levels . The association puts a “face on phar- or MPhA issues . macy” through media and outreach to health care entities who rely on MPhA for information and resources related to pharmacy Pharmacy News Flash services . Twice a week, Pharmacy News Flash is delivered by email to Through legislative representation, policy planning, and lobbying, members . These updates include news about national issues the association ensures that issues pertaining to pharmacy are not affecting pharmacists, along with local headlines and job open- overlooked or undercut . We fight for the rights of pharmacists and ings . pharmacy professionals to provide the highest level of care to the Career center patients they serve . MPhA encourages members to become involved Tailored to both our job seekers and employers, our Career in this process by being active in grassroots actions and events . As Center allows you to browse openings or post opportunities at a member, you will have access to important updates and resources your convenience . Search for Minnesota locations, or broaden made possible by your support. your search to outside states . The center holds a variety of Professional development and education options to tailor results to your needs . MPhA provides a variety of events throughout the year to keep members involved in pharmacy issues while offering continuing resources education, networking opportunities and fun! Events are listed Members receive special online access to pharmacy resources . on the MPhA Web site and are open to all . Members receive a dis- From MTM templates and brochures to information on immu- count on selected event programming, such as Annual Meeting, nizations, we save you valuable time by having these resources Fall Clinical Symposium, and Midwinter Conference . readily available to you for use in your practice . Online pharmacy education is also available through the MPhA Web site . Home Studies and Learn Something offer a variety of topics and timelines to fit your needs .

Minnesota Pharmacist n Winter 2012 23 mpha community pharmacy defense fund community pharmacy defense fund

The Community Pharmacy Defense Fund was established I agree to contribute $1,000 per store . by independent pharmacy owners and chain managers $1,000 x ______stores = $______to develop a pool of funding that could be used to fund initiatives to move pharmacy from a position of defend- ing the status quo to pursuing an aggressive agenda, thus I wish to contribute an additional $ ______to help combating the growing number of threats to community fund MPhA’s efforts to maintain a favorable climate for community pharmacy, chief among them being: pharmacy . • The inability to negotiate with third-party payers. • Predatory pricing strategies and below-cost sales. Name: ______• The growing threat of mandatory mail-order plans Organization: ______and discriminatory co-pay incentives . Address: ______• The threat of continuing cuts in pharmacy reimbursement in the public and private sectors . City: ______State: ______Zip: ______• The unrelenting drive by state officials to push the Phone: ______limits of personal importation of prescription drugs . Fax: ______• The probable increasing difficulty for rural pharmacies to remain viable and to transition ownership . Payment by: Check Mastercard Visa Discover Contributions of $1,000 per pharmacy are dedicated to If paying by credit card, all of the following fields are required. the Community Pharmacy Defense Fund, and held in trust by the Minnesota Pharmacists Association . The fund Card #: ______Expiration: ______is set up so that funding is directly applied to expenses associated with specific community pharmacy initiatives . Signature: ______Sec . Code: ______

Billing Address: Same as above Address: ______City: ______State: ______Zip: ______

Thank you to our defense fund supporters!

Those listed below contributed to the 2011 Community Pharmacy Defense Fund.

Astrup Drug Hennepin County Medical Center Scofield Drug & Gift Baron’s Pharmacy Iverson Corner Drug St Paul Corner Drug Breen’s Pharmacy Kemper Drug Thrifty White Pharmacy CVS Lakes Area Pharmacy Trumm Drug Dakota Drug Lewis Family Drug-Luverne Walgreens Erickson Drug New Richland Drug Warroad Heritage Genoa Healthcare Park Nicollet Health Services West Seventh Pharmacy Goodrich Pharmacy Phalen Family Pharmacy HealthPartners Planned Parenthood

24 Minnesota Pharmacist n Winter 2012 mpha pharmacy future fund pharmacy future fund The Minnesota Pharmacists Association established the I authorize my wholesaler(s) to place a one-tenth of a percent (0 .1%) Pharmacy Future Fund more than ten years ago to raise Pharmacy Future Fund contribution on my regular pharmaceutical funds that would allow MPhA to move our efforts to purchase invoices . I understand that this is a donation to the MPhA support community pharmacy in Minnesota to a new Pharmacy Future Fund . level . This fund has provided the vehicle for MPhA to maintain full-time advocacy, to take on third-party issues, and to address the business needs of community pharma- Name: ______cists . Pharmacy: ______While this program has enabled MPhA to pursue many objectives on behalf of community pharmacy, there are Address: ______more that have been identified as priorities that we fully intend to pursue . Our motivation to accomplish these tasks City: ______State: ______Zip: ______is high, and eventually we will get there – but resources behind motivation would enable a more rapid path to Phone: ______success . Fax: ______

Signature: ______Date: ______

Thank you to our future fund supporters! The following contributed to the 2011 Pharmacy Future Fund.

Bergh Pharmacy Globe Drug Pelican Drug Throndset Pharmacy Bergs Pharmacy Goodrich Pharmacy Peterson Thrifty White Trumm Drug #1 City Drug Goltz Pharmacy Prescription Center Trumm Drug Clinic Pharmacy Corner Drug, LeSueur Guidepoint Pharmacies Pro Pharmacy #1 Trumm Drug-Elbow Lake Crosstown Drug Herrmann Drug Pro Pharmacy #2 Trumm Drug-Glenwood Eagle Drug Lakes Area Pharmacy Ramsey Pharmacy Village Pharmacy & Gift Family Pharmacy South Lake Country Drug Range Drug Family Rexall Drug Moob Pharmacy St . Paul Corner Drug Foley Drug Parkers Trumm Drug Scofield Drug

please support mpha to address the needs of community pharmacy! Choose to support the Defense Fund or the Future Fund (or both!) by returning the information located under each fund to the MPhA office . If you have additional questions about our pharmacy funds, please call us during normal business hours (8:00 am to 5:00 pm) or send an email to info@mpha .org .

Mail or fax form(s) to: Minnesota Pharmacists Association 1000 Westgate Drive, Suite 252 | St . Paul, Minnesota 55114 651 .290 .2266 fax

Questions? 800-451-8349 or 651-697-1771

Minnesota Pharmacist n Winter 2012 25 MPha award nomination form

Please provide a letter of support for each award nominee describing in detail the reasons for the MPhA Awards Committee to consider your nominee . Include specific examples and/or details . Attach your nomination letter and any supporting documents to this form, including a current CV of nominee if possible . Nominations that do not include adequate information will not be considered until missing information is submitted. Nominators will be notified when nominations are received by the MPhA office and if additional information is required . Please see the MPhA Web site for additional award information and forms: www .mpha .org .

Harold R. Popp Award Sponsored by MPhA, the Popp Award recognizes one pharmacist annually for outstanding services to the profession of pharmacy . This is the highest honor bestowed by the association . Nominee’s Name: ______Workplace: ______

bowl of hygeia award Sponsored by Pfizer, the Bowl of Hygeia recognizes pharmacists who possess outstanding records of civic leadership in their own communities, from which their specific identification as a pharmacist reflects well on the profession . Nominee’s Name: ______Workplace: ______

distinguished young pharmacist award Sponsored by Pharmacists Mutual Companies, the Distinguished Young Pharmacist Award recognizes a young pharmacist within his/ her first ten years of practice who has distinguished himself/herself in the field of pharmacy . This pharmacist is also a participant in national pharmacy associations, professional programs, state association activities and/or community service . Nominee’s Name: ______Workplace: ______

excellence in Innovation award Sponsored by Upsher-Smith Laboratories, Inc ., the Excellence in Innovation Award recognizes innovative pharmacy practice resulting in improved patient care . Nominee’s Name: ______Workplace: ______

Pharmacy Technician award Presented by MPhA, the Pharmacy Technician Award recognizes a pharmacy technician in any practice setting who demonstrates leadership in their work and in their community . This includes demonstrating professionalism by participation in pharmacy association, professional programs and/or community service, promoting teamwork within the pharmacy, providing leadership and serving as a role model for coworkers, developing or assisting development of efficient safe procedures that support the provision of pharmaceutical care . Nominee’s Name: ______Workplace: ______

Recognizing Nominator’s information:

members who Name (please print): ______are an Phone: ______E-mail: ______inspiration to the field of Address:______pharmacy! City: ______state: ______Zip: ______

Please return all nominations by March 15, 2012 to the MPhA office.

26 Minnesota Pharmacist n Winter 2012

 to be determined by committee

June 9, 2012 ABSTRACT

 poster presentation

of author(s)*, institution and address corresponding author: MINNESOT A PHARMACISTS ASSOCIATION 128th ANNUAL CONFERENCE

 platform presentation Full name(s) Title: * Please indicate designation of author(s), e.g., R.Ph., PharmD, etc.

or fax: or fax:

writing an

and acceptance will be will and acceptance

Associate Professor, College of of College Professor, Associate

Statement of purpose Methodology Results and discussion Conclusion LCD projector* flash a or own your laptop bring (*You must transfer) file for drive

notification of recei notification

sent to this address) this to sent Entire abstract in one paragraph with no margins. INDENT 4 spaces for first line. No less than 10 - pitch type. Stay within borders! Abstract should contain:     Visual Aids needed, if platform  A 4’x 8’ Velcro B oard will be provided for poster presentations. A 6’ table will be provided only if requested by May 3, 2012 . Electr ical hookup is not available for poster presentations. E - mail address of contact person ( about you have questions If Thurday, May 3, 2012 to the MPhA office to [email protected] abstract, contact Todd Sorensen, Todd Sorensen, contact abstract, PharmD. Minnesota, of University Pharmacy, [email protected] 651 - 290 2266

Format for Abstract 1. 2. 3. 4. 5. 6. 7. Return abstract by:

Minnesota Pharmacist n Winter 2012 27 Pharmacy Professionals for Political Action

Contributions play a significant role in electing What is PharmPAC? and supporting pharmacy friendly legislators who PharmPAC is a legal, transparent, state monitored, bi-partisan Political understand the importance of pharmacies and Action Committee (PAC) whose major purpose is to influence the nomination or election of a candidate who supports the profession of pharmacy pharmacists. These legislators are willing to author and pharmacists. PharmPAC is a means to express united interests with one bills we need and vote for our issues in committee powerful voice. It is power in numbers. meetings and in legislative sessions. PharmPAC funds help make the Legislature as pharmacy-friendly and How does PharmPAC influence the political process? PharmPAC solicits contributions from individual pharmacists and pharmacy-knowledgeable as it can be. pharmacy technicians in Minnesota and combines them to make larger contributions to candidates and party units. PharmPAC funds are also used to attend fundraiser events for candidates and party units.

Who can receive PharmPAC funds? Candidates and incumbents who run for state office in Minnesota may receive PharmPAC funds. House of Representative members, Senators, the willingness to sponsor pharmacy initiatives. Governor, Secretary of State, Attorney General or any other state candidate • Caucus contributions are determined based on how many candidates who promotes and supports pharmacy can receive PAC funds. or officials from the caucus attend the event, timing and effectiveness of contribution amount. Which funds are accepted by PharmPAC? Individual contributions are accepted, but corporate contributions are pro- What are the guidelines PharmPAC uses to disperse funds? hibited. For each contribution over $20.00 a record of the donor will be Recommendations on which candidates are made by those most involved kept. Anonymous contributions can not be accepted by PharmPAC. Other with the political process, ie lobbyists and PAC volunteers, Chair or Vice political committees, political funds or political party units registered in Chair who lobby or have legislative and campaign experience. Contribu- MN may also contribute to PharmPAC. tions are disbursed in a non-partisan manner. The qualification is “pharmacy friendly” not party friendly. Persons who shall receive preference when determining contributions, or ways to define “pharmacy friendly”: Is PharmPAC regulated? PharmPAC is regulated by the Minnesota Campaign Finance Board. The • Elected officials who have sponsored or authored legislation for phar- state of Minnesota has some of the most strict campaign finance laws in the macists or pharmacy. nation. All information from PharmPAC, other PACs and party units is re- • Chair persons of committees which deliberate issues relevant to phar- corded and filed with the Board. This information is available to the public macy. at www.cfboard.state.mn.us • Elected officials who made difficult votes in favor of pharmacy initiatives. • Elected officials who attend and speak at pharmacy events. Are there limits to how much a person can contribute? An individual may contribute unlimited amounts to PharmPAC. But • Elected officials or challengers who pledge support and demonstrate PharmPAC is limited as to how much it can contribute to candidates and willingness to sponsor pharmacy initiatives. party units. Why have a PAC? PACs are an important part of the American political process. They have How does PharmPAC determine who to contribute to? Contributions are determined with recommendations by the Chair, been around since 1944, when the Congress of Industrial Organizations Treasurer, Deputy Treasurer, the Volunteer Committee, contributors, and (CIO) formed the first one to raise money for the re-election of President others. Contributions are given to candidates or elected officials who are Franklin D. Roosevelt. PharmPAC is another way the profession of phar- determined to be pharmacy friendly in a nonpartisan manner. macy maintains its presence in a crowded arena of special interests in the Factors used to determine “pharmacy friendly” include but are not limited state’s political process. to: • Elected officials who have sponsored or authored legislation for pharma- What’s in it for me? cists or pharmacy. PharmPAC is an exciting way to be directly involved in the political • Chair persons of committees which deliberate issues relevant to phar- process. Being involved with PharmPAC enables you to affect your profes- macy. sional livelihood in a powerful, positive way. By contributing to PharmPAC • Elected officials who made difficult votes in favor of pharmacy initiatives. you will receive information about candidates and events in your area. You • Elected officials who attend or speak at pharmacy events. will know who supports your professional interests at the Minnesota state • Elected officials or challengers who pledge support and demonstrate legislature. You will be a part of influencing the political process.

28 Minnesota Pharmacist n Winter 2012 minnesota senators

Name Party Dist Rm Building Phone Email Bakk, Thomas M . DFL 6 147 State 296-8881 Use Mail Form Benson, Michelle R . R 49 G-24 Capitol 296-3219 sen .michelle .benson@senate .mn Bonoff, Terri E . DFL 43 133 State 296-4314 sen .terri .bonoff@senate .mn Brown, David M . R 16 205 Capitol 296-8075 sen .david .brown@senate .mn Carlson, John R 4 320 Capitol 296-4913 sen .john .carlson@senate .mn Chamberlain, Roger C . R 53 306 Capitol 296-1253 sen .roger .chamberlain@senate .mn Cohen, Richard J . DFL 64 109 State 296-5931 Use Mail Form Dahms, Gary H . R 21 111 Capitol 296-8138 sen .gary .dahms@senate .mn Daley, Theodore J . “Ted” R 38 G-24 Capitol 297-8073 sen .ted .daley@senate .mn DeKruif, Al R 25 G-24 Capitol 296-1279 sen .al .dekruif@senate .mn Dibble, D . Scott DFL 60 115 State 296-4191 sen .scott .dibble@senate .mn Dziedzic, Kari DFL 59 27 State 296-7809 sen .kari .dziedzic@senate .mn Eaton, Chris A . DFL 46 21 State 296-8869 Use Mail Form Fischbach, Michelle L . R 14 226 Capitol 296-2084 sen .michelle .fischbach@senate .mn Gazelka, Paul E . R 12 325 Capitol 296-4875 sen .paul .gazelka@senate .mn Gerlach, Chris R 37 120 Capitol 296-4120 sen .chris .gerlach@senate .mn Gimse, Joe R 13 303 Capitol 296-3826 sen .joe .gimse@senate .mn Goodwin, Barb J . DFL 50 123 State 296-4334 sen .barb .goodwin@senate .mn Senate Floor ©Bill Nau Hall, Dan D . R 40 325 Capitol 296-5975 sen .dan .hall@senate .mn Hann, David W . R 42 328 Capitol 296-1749 Use Mail Form Harrington, John M . DFL 67 17 State 296-5285 sen .john .harrington@senate .mn Hayden, Jeff DFL 61 151 State 296-4261 sen .jeff .hayden@senate .mn Higgins, Linda DFL 58 113 State 296-9246 sen .linda .higgins@senate .mn Hoffman, Gretchen M . R 10 124 Capitol 296-5655 sen .gretchen .hoffman@senate .mn Howe, John R 28 323 Capitol 296-4264 sen .john .howe@senate .mn Ingebrigtsen, Bill R 11 303 Capitol 297-8063 sen .bill .ingebrigtsen@senate .mn Jungbauer, Michael J . R 48 235 Capitol 296-3733 sen .mike .jungbauer@senate .mn Kelash, Kenneth S . DFL 63 129 State 297-8061 sen .kenneth .kelash@senate .mn Capitol Koch, Amy T . R 19 322 Capitol 296-5981 sen .amy .koch@senate .mn 75 Rev . Dr . Martin Kruse, Benjamin A . R 47 124 Capitol 296-4154 sen .benjamin .kruse@senate .mn Luther King Jr . Blvd . Kubly, Gary W . DFL 20 103 State 296-5094 sen .gary .kubly@senate .mn Room (See numbers across) Langseth, Keith DFL 9 139 State 296-3205 Use Mail Form St . Paul, MN 55155-1606 Latz, Ron DFL 44 121 State 297-8065 sen .ron .latz@senate .mn Lillie, Ted H . R 56 124 Capitol 296-4166 sen .ted .lillie@senate .mn State Office Building Limmer, Warren R 32 122 Capitol 296-2159 sen .warren .limmer@senate .mn 100 Rev . Dr . Martin Lourey, Tony DFL 8 125 State 296-0293 sen .tony .lourey@senate .mn Luther King Jr . Blvd . Magnus, Doug R 22 205 Capitol 296-5650 sen .doug .magnus@senate .mn Room (See numbers across) Marty, John DFL 54 119 State 296-5645 Use Mail Form St . Paul, MN 55155-1206 McGuire, Mary Jo DFL 66 23 State 296-5537 Use Mail Form Metzen, James P . DFL 39 15 State 296-4370 sen .jim .metzen@senate .mn Michel, Geoff R 41 208 Capitol 296-6238 sen .geoff .michel@senate .mn www .senate .leg .state .mn .us Miller, Jeremy R . R 31 320 Capitol 296-5649 sen .jeremy .miller@senate .mn Nelson, Carla J . R 30 111 Capitol 296-4848 sen .carla .nelson@senate .mn • Find your district Newman, Scott J . R 18 301 Capitol 296-4131 sen .scott .newman@senate .mn Nienow, Sean R . R 17 120 Capitol 296-5419 sen .sean .nienow@senate .mn • Find your senator Olson, Gen R 33 235 Capitol 296-1282 sen .gen .olson@senate .mn • Learn about your senator Ortman, Julianne E . R 34 120 Capitol 296-4837 sen .julianne .ortman@senate .mn • Contact/email your senator Pappas, Sandra L . DFL 65 143 State 296-1802 Use Mail Form Parry, Mike R 26 309 Capitol 296-9457 sen .mike .parry@senate .mn Pederson, John C . R 15 G-24 Capitol 296-6455 sen .john .pederson@senate .mn Reinert, Roger J . DFL 7 149 State 296-4188 sen .roger .reinert@senate .mn If you don’t know what district Rest, Ann H . DFL 45 105 State 296-2889 Use Mail Form you are in, visit the Minnesota Robling, Claire A . R 35 226 Capitol 296-4123 sen .claire .robling@senate .mn Senate Web site to find out who Rosen, Julie A . R 24 317 Capitol 296-5713 sen .julie .rosen@senate .mn represents you . Saxhaug, Tom DFL 3 135 State 296-4136 sen .tom .saxhaug@senate .mn Senjem, David H . R 29 121 Capitol 296-3903 sen .david .senjem@senate .mn Sheran, Kathy DFL 23 127 State 296-6153 sen .kathy .sheran@senate .mn Sieben, Katie DFL 57 117 State 297-8060 sen .katie .sieben@senate .mn Skoe, Rod DFL 2 107 State 296-4196 sen .rod .skoe@senate .mn Sparks, Dan DFL 27 19 State 296-9248 sen .daniel .sparks@senate .mn Stumpf, LeRoy A . DFL 1 145 State 296-8660 Use Mail Form Thompson, Dave R 36 323 Capitol 296-5252 sen .dave .thompson@senate .mn Tomassoni, David J . DFL 5 25 State 296-8017 sen .david .tomassoni@senate .mn Torres Ray, Patricia DFL 62 131 State 296-4274 sen .patricia .torres .ray@senate .mn Vandeveer, Ray R 52 328 Capitol 296-4351 sen .ray .vandeveer@senate .mn Wiger, Charles W . DFL 55 141 State 296-6820 sen .chuck .wiger@senate .mn Wolf, Pam R 51 306 Capitol 296-2556 sen .pam .wolf@senate .mn

Minnesota Pharmacist n Winter 2012 29 minnesota house of representatives

Name PartY dist rm oFFice Phone email Abeler, Jim R 48B 479 651-296-1729 rep .jim .abeler@house .mn Allen, Susan DFL 61B 389 651-296-7152 rep .susan .allen@house .mn Anderson, Bruce R 19A 365 651-296-5063 rep .bruce .anderson@house .mn Anderson, Sarah R 43A 549 651-296-5511 rep .sarah .anderson@house .mn Anderson, Paul R 13A 445 651-296-4317 rep .paul .anderson@house .mn Anderson, Diane R 38A 525 651-296-3533 rep .diane .anderson@house .mn Anzelc, Tom DFL 03A 307 651-296-4936 rep .tom .anzelc@house .mn Atkins, Joe DFL 39B 209 651-296-4192 rep .joe .atkins@house .mn Banaian, King R 15B 411 651-296-6612 rep .king .banaian@house .mn Barrett, Bob R 17B 413 651-296-5377 rep .bob .barrett@house .mn Beard, Michael R 35A 417 651-296-8872 rep .mike .beard@house .mn Benson, John DFL 43B 289 651-296-9934 rep .john .benson@house .mn Benson, Mike R 30B 515 651-296-4378 rep .mike .benson@house .mn Bills, Kurt R 37B 533 651-296-4306 rep .kurt .bills@house .mn Brynaert, Kathy DFL 23B 327 651-296-3248 rep .kathy .brynaert@house .mn Buesgens, Mark R 35B 381 651-296-5185 rep .mark .buesgens@house .mn Carlson Sr ., Lyndon DFL 45B 283 651-296-4255 rep .lyndon .carlson@house .mn Capitol ©Bill Nau Champion, Bobby Joe DFL 58B 329 651-296-8659 rep .bobby .champion@house .mn Clark, Karen DFL 61A 277 651-296-0294 rep .karen .clark@house .mn Cornish, Tony R 24B 437 651-296-4240 rep .tony .cornish@house .mn Crawford, Roger R 08B 421 651-296-0518 rep .roger .crawford@house .mn Daudt, Kurt R 17A 487 651-296-5364 rep .kurt .daudt@house .mn Davids, Greg R 31B 585 651-296-9278 rep .greg .davids@house .mn Davnie, Jim DFL 62A 215 651-296-0173 rep .jim .davnie@house .mn Dean, Matt R 52B 459 651-296-3018 rep .matt .dean@house .mn Dettmer, Bob R 52A 473 651-296-4124 rep .bob .dettmer@house .mn Dill, David DFL 06A 273 651-296-2190 rep .david .dill@house .mn State Office Building Dittrich, Denise DFL 47A 311 651-296-5513 rep .denise .dittrich@house .mn 100 Rev . Dr . Martin Doepke, Connie R 33B 579 651-296-4315 rep .connie .doepke@house .mn Downey, Keith R 41A 407 651-296-4363 rep .keith .downey@house .mn Luther King Jr . Blvd . Drazkowski, Steve R 28B 401 651-296-2273 rep .steve .drazkowski@house .mn Room (See numbers across) Eken, Kent DFL 02A 243 651-296-9918 rep .kent .eken@house .mn St . Paul, MN 55155-1206 Erickson, Sondra R 16A 509 651-296-6746 rep .sondra .erickson@house .mn Fabian, Dan R 01A 431 651-296-9635 rep .dan .fabian@house .mn www .house .leg .state .mn .us Falk, Andrew DFL 20A 239 651-296-4228 rep .andrew .falk@house .mn Franson, Mary R 11B 429 651-296-3201 rep .mary .franson@house .mn • Find your district Fritz, Patti DFL 26B 253 651-296-8237 rep .patti .fritz@house .mn • Find your representative Garofalo, Pat R 36B 537 651-296-1069 rep .pat .garofalo@house .mn Gauthier, Kerry DFL 07B 225 651-296-4246 rep .kerry .gauthier@house .mn • Learn about your Gottwalt, Steve R 15A 485 651-296-6316 rep .steve .gottwalt@house .mn representative Greene, Marion DFL 60A 331 651-296-0171 rep .marion .greene@house .mn • Contact/email your Greiling, Mindy DFL 54A 393 651-296-5387 rep .mindy .greiling@house .mn representative Gruenhagen, Glenn R 25A 575 651-296-4229 rep .glenn .gruenhagen@house .mn Gunther, Bob R 24A 591 651-296-3240 rep .bob .gunther@house .mn Hackbarth, Tom R 48A 409 651-296-2439 rep .tom .hackbarth@house .mn Hamilton, Rod R 22B 559 651-296-5373 rep .rod .hamilton@house .mn If you don’t know what district Hancock, David R 02B 529 651-296-4265 rep .david .hancock@house .mn you are in, visit the Minnesota Hansen, Rick DFL 39A 247 651-296-6828 rep .rick .hansen@house .mn House Web site to find out who Hausman, Alice DFL 66B 255 651-296-3824 rep .alice .hausman@house .mn represents you . Hilstrom, Debra DFL 46B 261 651-296-3709 rep .debra .hilstrom@house .mn Hilty, Bill DFL 08A 207 651-296-4308 rep .bill .hilty@house .mn Holberg, Mary Liz R 36A 453 651-296-6926 rep .maryliz .holberg@house .mn Hoppe, Joe R 34B 563 651-296-5066 rep .joe .hoppe@house .mn Hornstein, Frank DFL 60B 213 651-296-9281 rep .frank .hornstein@house .mn Hortman, Melissa DFL 47B 377 651-296-4280 rep .melissa .hortman@house .mn Hosch, Larry DFL 14B 349 651-296-4373 rep .larry .hosch@house .mn Howes, Larry R 04B 491 651-296-2451 rep .larry .howes@house mn. Huntley, Thomas DFL 07A 351 651-296-2228 rep .thomas .huntley@house .mn Johnson, Sheldon DFL 67B 217 651-296-4201 rep .sheldon .johnson@house .mn Kahn, Phyllis DFL 59B 353 651-296-4257 rep .phyllis .kahn@house .mn Kath, Kory DFL 26A 201 651-296-5368 rep .kory .kath@house .mn Kelly, Tim R 28A 565 651-296-8635 rep .tim .kelly@house .mn Kieffer, Andrea R 56B 531 651-296-1147 rep .andrea .kieffer@house .mn Kiel, Debra R 01B 423 651-296-5091 rep .deb .kiel@house .mn Kiffmeyer, Mary R 16B 501 651-296-4237 rep .mary .kiffmeyer@house .mn Knuth, Kate DFL 50B 323 651-296-0141 rep .kate .knuth@house .mn Koenen, Lyle DFL 20B 241 651-296-4346 rep .lyle .koenen@house .mn Kriesel, John R 57A 451 651-296-4342 rep .john .kriesel@house .mn Laine, Carolyn DFL 50A 287 651-296-4331 rep .carolyn .laine@house .mn Lanning, Morrie R 09A 379 651-296-5515 rep .morrie .lanning@house .mn Leidiger, Ernie R 34A 415 651-296-4282 rep .ernie .leidiger@house .mn

30 Minnesota Pharmacist n Winter 2012 minnesota house of representatives

Name PartY dist rm oFFice Phone email LeMieur, Mike R 12B 567 651-296-4247 rep .mike .lemieur@house .mn Lenczewski, Ann DFL 40B 317 651-296-4218 rep .ann .lenczewski@house .mn Lesch, John DFL 66A 315 651-296-4224 rep .john .lesch@house .mn Liebling, Tina DFL 30A 357 651-296-0573 rep .tina .liebling@house .mn Lillie, Leon DFL 55A 281 651-296-1188 rep .leon .lillie@house .mn my district: Loeffler, Diane DFL 59A 335 651-296-4219 rep .diane .loeffler@house .mn Lohmer, Kathy R 56A 521 651-296-4244 rep .kathy .lohmer@house .mn Loon, Jenifer R 42B 403 651-296-7449 rep .jenifer .loon@house .mn Mack, Tara R 37A 557 651-296-5506 rep .tara .mack@house .mn Mahoney, Tim DFL 67A 237 651-296-4277 rep .tim .mahoney@house .mn my representative: Mariani, Carlos DFL 65B 203 651-296-9714 rep .carlos .mariani@house .mn Marquart, Paul DFL 09B 313 651-296-6829 rep .paul .marquart@house .mn Mazorol, Pat R 41B 581 651-296-7803 rep .pat .mazorol@house .mn McDonald, Joe R 19B 523 651-296-4336 rep .joe .mcdonald@house .mn McElfatrick, Carolyn R 03B 545 651-296-2365 rep .carolyn .mcelfatrick@house .mn McFarlane, Carol R 53B 597 651-296-5363 rep .carol .mcfarlane@house .mn McNamara, Denny R 57B 375 651-296-3135 rep .denny .mcnamara@house .mn Melin, Carly DFL 05B 309 651-296-0172 rep .carly .melin@house .mn Moran, Rena DFL 65A 227 651-296-5158 rep .rena .moran@house .mn Morrow, Terry DFL 23A 211 651-296-8634 rep .terry .morrow@house .mn Mullery, Joe DFL 58A 387 651-296-4262 rep .joe .mullery@house .mn Murdock, Mark R 10B 593 651-296-4293 rep .mark .murdock@house .mn Murphy, Erin DFL 64A 345 651-296-8799 rep .erin .murphy@house .mn Murphy, Mary DFL 06B 343 651-296-2676 rep .mary .murphy@house .mn Murray, Rich R 27A 439 651-296-8216 rep .rich .murray@house .mn Myhra, Pam R 40A 517 651-296-4212 rep .pam .myhra@house .mn Nelson, Michael V . DFL 46A 229 651-296-3751 rep .michael .nelson@house .mn Nornes, Bud R 10A 471 651-296-4946 rep .bud .nornes@house .mn Norton, Kim DFL 29B 233 651-296-9249 rep .kim .norton@house .mn O’Driscoll, Tim R 14A 369 651-296-7808 rep .tim .odriscoll@house .mn Paymar, Michael DFL 64B 301 651-296-4199 rep .michael .paymar@house .mn Pelowski Jr ., Gene DFL 31A 295 651-296-8637 rep .gene .pelowski@house .mn Peppin, Joyce R 32A 503 651-296-7806 rep .joyce .peppin@house .mn Persell, John DFL 04A 223 651-296-5516 rep .john .persell@house .mn notes: Petersen, Branden R 49B 577 651-296-5369 rep .branden .petersen@house .mn Peterson, Sandra DFL 45A 337 651-296-4176 rep .sandra .peterson@house .mn Poppe, Jeanne DFL 27B 291 651-296-4193 rep .jeanne .poppe@house .mn Quam, Duane R 29A 569 651-296-9236 rep .duane .quam@house .mn Rukavina, Tom DFL 05A 303 651-296-0170 rep .tom .rukavina@house .mn Runbeck, Linda R 53A 583 651-296-2907 rep .linda .runbeck@house .mn Sanders, Tim R 51A 449 651-296-4226 rep .tim .sanders@house .mn Scalze, Bev DFL 54B 259 651-296-7153 rep .bev .scalze@house .mn Schomacker, Joe R 22A 433 651-296-5505 rep .joe .schomacker@house .mn Scott, Peggy R 49A 477 651-296-4231 rep .peggy .scott@house .mn Shimanski, Ron R 18A 367 651-296-1534 rep .ron .shimanski@house .mn Simon, Steve DFL 44A 279 651-296-9889 rep .steve .simon@house .mn Slawik, Nora DFL 55B 245 651-296-7807 rep .nora .slawik@house .mn Slocum, Linda DFL 63B 359 651-296-7158 rep .linda .slocum@house .mn Smith, Steve R 33A 543 651-296-9188 rep .steve .smith@house .mn Stensrud, Kirk R 42A 553 651-296-3964 rep .kirk .stensrud@house .mn Swedzinski, Chris R 21A 527 651-296-5374 rep .chris .swedzinski@house .mn Thissen, Paul DFL 63A 267 651-296-5375 rep .paul .thissen@house .mn Tillberry, Tom DFL 51B 231 651-296-5510 rep .tom .tillberry@house .mn Torkelson, Paul R 21B 371 651-296-9303 rep .paul .torkelson@house .mn Urdahl, Dean R 18B 571 651-296-4344 rep .dean .urdahl@house .mn Vogel, Bruce R 13B 507 651-296-6206 rep .bruce .vogel@house .mn Wagenius, Jean DFL 62B 251 651-296-4200 rep .jean .wagenius@house .mn Ward, John DFL 12A 221 651-296-4333 rep .john .ward@house .mn Wardlow, Doug R 38B 551 651-296-4128 rep .doug .wardlow@house .mn Westrom, Torrey R 11A 443 651-296-4929 rep .torrey westrom@house. .mn Winkler, Ryan DFL 44B 321 651-296-7026 rep .ryan .winkler@house .mn Woodard, Kelby R 25B 539 651-296-7065 rep .kelby .woodard@house .mn Zellers, Kurt R 32B 463 651-296-5502 rep .kurt .zellers@house .mn

Minnesota Pharmacist n Winter 2012 31 united states Minnesota house & senate

Congresswoman Michele Bachmann senator Amy Klobuchar Sixth Congressional District of Minnesota http://klobuchar.senate.gov http://bachmann .house .gov • Washington, DC • Washington, DC 302 Hart Office Building 412 Cannon HOB Washington, DC 20510 Washington, DC 20515 202-224-3244 • 202-228-2186 fax 202-225-2331 • 202-225-6475 fax • Woodbury • Metro 1200 Washington Avenue S, Suite 250 Please note that mail delivery to Washington can be 6043 Hudson Road, Suite 330 Minneapolis, MN 55415 • 612-727-5220 delayed by up to 10 days due to security screening. If Woodbury, MN 55125 • 651-731-5400 your message is urgent, fax your letter to Washington, • ST . Cloud/Waite Park • Rochester contact their district office, or send an email through 110 2nd Street S, Suite 232 1134 7th Street NW their Web site. Waite Park, MN 56387 • 320-253-5931 Rochester, MN 55901 • 507-288-5321 Congressman Collin Peterson • Moorhead Congressman timothy Walz Seventh Congressional District of Minnesota 121 4th Street S First Congressional District of Minnesota http://collinpeterson .house .gov Moorhead, MN 56560 • 218-287-2219 http://walz .house .gov • WASHINGTON, DC • Iron Range • Washington, DC 2211 Rayburn HOB Olcott Plaza, Suite 105 1529 Longworth House Office Building Washington, DC 20515 820 9th Street N Washington, DC 20515 • 202-225-2472 202-225-2165 • 202-225-1593 fax Virginia, MN 55792 • 218-741-9690 • Rochester • Detroit Lakes 1134 7th Street NW 714 Lake Avenue, Suite 107 senator al franken Rochester, MN 55901 • 507-206-0643 Detroit Lakes, MN 56501 • 218-847-5056 http://franken.senate.gov • Mankato • Marshall 227 Main Street E, #220 1420 East College Drive, SW/WC • Washington, DC Mankato, MN 56001 • 507-388-2149 Marshall, MN 56258 • 507-537-2299 320 Hart Senate Office Building Washington, DC 20510 • 202-224-5641 Congressman John Kline • Montevideo Second Congressional District of Minnesota 100 First Street N • st paul http://kline .house .gov Montevideo, MN 56265 • 320-269-8888 60 East Plato Blvd, Suite 220 • Washington, DC • Red Lake Falls Saint Paul, MN 55107 • 651-221-1016 1429 Longworth House Office Building MN Wheat Growers Building • saint peter Washington, DC 20515 2603 Wheat Drive 208 S Minnesota Ave ., Suite 6 202-225-2271 • 202-225-2595 fax Red Lake Falls, MN 56750 • 218-253-4356 Saint Peter, MN 56082 • 507-931-7345 • Burnsville • Redwood Falls 230 East 3rd Street, P .O . Box 50 • saint cloud 101 West Burnsville Pkwy ., Ste . #201 916 W St . Germain St ., Suite 110 Burnsville, MN 55337 • 952-808-1213 Redwood Falls, MN 56283 • 507-637-2270 • Willmar Saint Cloud, MN 56301 • 320-251-2721 Congressman eric paulsen 320 4th St SW, Centre Point Mall • duluth Third Congressional District of Minnesota Willmar, MN 56201 • 320-235-1061 515 W 1st St ., Suite 104 http://paulsen .house .gov Duluth, MN 55082 • 218-722-2390 • Washington, DC Congressman Chip cravaack 126 Cannon House Office Building Eighth Congressional District of Minnesota Washington, DC 20515 http://chipcravaack .house .gov 202-225-2871 • 202-225-6351 fax • WASHINGTON, DC • eden prairie 508 Cannon HOB 250 Prairie Center Drive, Suite 230 Washington, DC 20515 Eden Prairie, MN 55344 • 952-405-8510 202-225-6211 • 202-225-0699 fax • NORTH BRANCH Congresswoman Betty McCollum 6448 Main St ., Suite Ste 6 Fourth Congressional District of Minnesota North Branch, Minnesota 55056 • 651-237-8220 http://www .mccollum .house .gov or 1-888-563-7390 • Washington, DC Fax: 651-237-8225 1714 Longworth House Office Building Washington, DC 20515 202-225-6631 • 202-225-1968 fax • Saint Paul 165 Western Avenue N, Suite 17 St. Paul, MN 55102 • 651-224-9191 Congressman keith ellison Fifth Congressional District of Minnesota • Washington, DC 1130 Longworth House Office Building Washington, DC 20515 202-225-4755 • 202-225-4886 fax • Minneapolis 2100 Plymouth Avenue N Minneapolis, MN 55411 • 612-522-1212

32 Minnesota Pharmacist n Winter 2012 minnesota pharmacy resources

Minnesota Board of Pharmacy Members university of minnesota College of Pharmacy President: James Koppen College of Pharmacy Vice President: Laura J. Schwartzwald University of Minnesota Pharmacist Members: Karen Bergrud, Bob Goetz, Kay Hanson 5-130 Weaver-Densford Hall Public Members: Ikram–ul–Huq, Stuart Williams 308 Harvard Street SE Minneapolis, MN 55455 612-624-1900 minnesota department 612-624-2974 fax of human services www.pharmacy.umn.edu The Minnesota Department of Human Services (DHS) helps people meet their basic needs by providing or administering health Dean Marilyn K . Speedie, Ph .D . care coverage, economic assistance, and a variety of services for 612-624-1900 children, people with disabilities and older Minnesotans . DHS programs include Medical Assistance (MA), MinnesotaCare, university of minnesota Minnesota Family Investment Program (Minnesota’s version of College of Pharmacy, duluth the federal Temporary Assistance for Needy Families program), University of Minnesota General Assistance (GA), the Prescription Drug Program, child College of Pharmacy, Duluth protection, child support enforcement, child welfare services, and 386 Kirby Plaza services for people who are mentally ill, chemically dependent or 1208 Kirby Drive have physical or developmental disabilities . Duluth, MN 55812-3095 218-726-6000 www.dhs.state.mn.us 218-726-6500 fax www.pharmacy.umn.edu/duluth Drug Utilization Review board (DUR) The Drug Utilization Review Board (DUR) selects specific drug entities or therapeutic classes to be targeted for provider and recip- minnesota board of pharmacy ient educational interventions, and provides guidelines for their The Minnesota Board of Pharmacy (BOP) exists to protect the use . The DUR board is comprised of four licensed physicians, at public from adulterated, misbranded, and illicit drugs, and from least three licensed pharmacists and one consumer representative, unethical or unprofessional conduct on the part of pharmacists or with the remaining members being licensed health care profession- other licensees, and to provide a reasonable assurance of profes- als with clinically appropriate knowledge in prescribing, dispens- sional competency in the practice of pharmacy by enforcing the ing, and monitoring outpatient drugs . DUR board meetings are Pharmacy Practice Act M .S . 151, State Controlled Substances Act held four times a year . Appointing authority: Commissioner of M .S . 152 and various other statutes . The board strives to fulfill Human Services . Compensation: $50 per member per meeting its mission through a combination of regulatory activity, technical plus mileage . (Minnesota Statutes 256B .0625, subd . 13a) consultation and support for pharmacy practices through the issuance of advisories on pharmacy practice issues, and through Drug Formulary Committee (DFC) education of pharmacy practitioners . The Drug Formulary Committee (DFC) is charged with reviewing and recommending which drugs require authorization . The The Board of Pharmacy consists of seven board members, DFC also reviews drugs for which coverage is optional under appointed by the governor; five board members must be pharma- federal and state law . (For possible inclusion in the Medicaid cists, and two members must be public members . The board regu- fee-for-service formulary .) The DFC is comprised of four physi- lates pharmacists, pharmacies, pharmacy technicians, controlled cians, at least three pharmacists, a consumer representative, and substance researchers, drug wholesalers and drug manufacturers . knowledgeable health care professionals . DFC meetings are open The board approves licenses or registrations for these individuals to the public and public comments are taken for an additional 30 or businesses, and also decides when to impose disciplinary action . days following a DFC recommendation to require prior authori- Minnesota Board of Pharmacy zation for a drug . The Department of Human Services provides Cody C. Wiberg, Executive Director the DFC with information regarding the impact that placing a 2829 University Ave, SE, Suite 530 drug on authorization will have on the quality and cost of patient Minneapolis, MN 55414 care . Appointing authority: Commissioner of Human Services . 651-201-2825 Compensation: None . (Minnesota Statutes 256B .0625, subd . 13) 651-201-2837 fax 800-627-3529 hearing impaired www.phcybrd.state.mn.us

Minnesota Pharmacist n Winter 2012 33 2012 MPha award categories recognize those making a difference in the profession of pharmacy.

The association annually recognizes leaders in the field of distinguished young pharmacist pharmacy . Please help us identify pharmacy leaders by submit- Sponsored by Pharmacists Mutual Companies, the ting a nomination form(s) and letters of support to the MPhA Distinguished Young Pharmacist Award recognizes a young office . More information can be found on the MPhA Web site . pharmacist within his/her first ten years of practice who has dis- Following are descriptions of each award, and past recipients, tinguished himself/herself in the field of pharmacy . This phar- beginning with the most recent 2011 recipients . macist is also a participant in national pharmacy associations, professional programs, state association activities and/or com- Harold r. popp award munity service . This award is presented at the MPhA Annual Sponsored by the Minnesota Pharmacists Association, the Popp Meeting . Award was established by MPhA in 1969 in honor of the late Sarah Leslie Michelle Johnson Scott Benson Senator Harold R . Popp to recognize one pharmacist annually Dan Rehrauer Debra Sisson Sherwood Peterson, Jr . for outstanding services to the profession of pharmacy . This is Julie Fike Laura Odell Nancy Ruhland the highest honor bestowed by the association . This award is Sarah Westberg Molly Ekstrand Mary Hayney presented at the MPhA Annual Meeting . Stephanie Davis Denise Wolff Jeffrey Shapiro Michelle Aytay Roger McDannold Lucy Johnson Rod Carter David Holmstrom Lowell J . Anderson Mark Dewey John Hoeschen Kathryn Nygren Marilyn Eelkema Gary Raines John H . Nelson Terry Hietpas Jason Varin Randy Seifert Barb Jones Frank D . DiGangi Todd D . Sorensen Karen Schramm Chris Koentopp Karl Leupold Neal W . Schwartau Paul Iverson Gilbert Banker Kendall B . Macho Dale Olson Howard Juni J . Roger Vadheim Excellence in Innovation Steven Simenson Doris Calhoun Kitty Alcott Sponsored by Upsher Smith, the Excellence in Innovation Marilyn K . Speedie Donald P . Gibson William Appel award recognizes innovative pharmacy practice resulting in James Armbrustser S . Bruce Benson Russel F . King improved patient care . This award is presented at the MPhA John Stevens Gary Schneider Charles V . Netz Annual Meeting . Herbert Whittemore Russ Boogren Henry M . Moen Michael A . Kelly Carl Oberg Jr . Arnold D . Delger Camille Kundel Jeremy Johnson Sherwood Peterson Jr . Marv Dyrstad Barry Krelitz John E . Quistgard Amanda Brummel Daniel J . Rehrauer Peters Institute Keith Pearson Roland Leuzinger Shannon Reidt J .D . Anderson Laura Miller Julie K . Johnson Lawrence C . Weaver Bruce Thompson Tiffany D . Elton Tom Jackson Vyvy Vo Ronald Hartmann John Loch April Hanson Paul Iverson Keith Pearson bowl of hygeia Sponsored by Wyeth Pharmaceuticals, the Bowl of Hygeia rec- PHARMACY TECHNICIAN AWARD ognizes pharmacists who possess outstanding records of civic Presented by MPhA, the Pharmacy Technician Award rec- leadership in their own communities, from which their specific ognizes a pharmacy technician in any practice setting who identification as a pharmacist reflects well on the profession . demonstrates leadership in their work and in their community . This award is presented at the MPhA Annual Meeting . This includes demonstrating professionalism by participation in John Hoeschen Chuck Frost Carl W . Oberg, Jr . pharmacy association, professional programs and/or community Gregory Trumm Robert Warren Russell Boogren, Jr . service, promoting teamwork within the pharmacy, providing Patricia Lind Don Dinndorf Jack R . Andrews Gary Raines Herb Whittemore Frank E . DiGangi leadership and serving as a role model for coworkers, developing Vern Peterson James Alexander Roger Vadheim or assisting development of efficient safe procedures that support Paul Iverson John H . Nelson Russell F . King, Jr . the provision of pharmaceutical care . This award is presented at Brian Isetts Donald P . Gibson Burton Magnuson the annual MPhA/MSHP Technician Conference . Steven T . Simenson Brad Stanius Andrew G . Sanders Richard C . Sundberg Gary Schneider Bernard H . Trygstad Robbin Leach Jennifer Sandberg Jamie Jesnowski Terry L . Hartmann Richard Kienzle Willard J . Hadley Carole Lentz Sandra Christensen Heidi Miller Sherwood Peterson, Jr . Harold McMahon Maynard L . Johnson Tina Nathe Cheryl Blegen Julie K . Johnson Doris Calhoun Argyll W . Peterson Dale Olson Andrew Johnson William D . Nelson Please provide a letter of support for each award nominee describing in John Stevens Robert W . Foster Orace Hanson detail the reasons for the MPhA Awards Committee to consider your nomi- Mike Hart Lowell J . Anderson Paul C . Anderson Howard Juni Ronald O . Leuzinger Arnold M . Grais nee. Include specific examples and/or details. Attach your nomination letter Robert Reutzel Earl A . Schwerman Ted F . Maier and any supporting documents to the form on page 26, including a cur- Robert Setzer Arnold D . Delger rent CV of nominee if possible. Nominations that do not include adequate information will not be considered until missing information is submitted. Nominators will be notified when nominations are received by the MPhA office and if additional information is required. Please see the MPhA Web site for additional award information and forms: www.mpha.org.

34 Minnesota Pharmacist n Winter 2012 The Minnesota Pharmacists Foundation is an organization that invests in public health through the profession of pharmacy.

The Minnesota Pharmacists Foundation formed in May 2003 to enhance patient care practices and the development of leadership opportunities for Minnesota pharmacists . The foundation promotes and communicates leading-edge practice innovations that consistently demonstrate improved patient outcomes .

Foundation GOALS: Create a strong future for pharmacy by investing in its pharmacists of tomorrow . Award annual scholarships to pharmacy students attending the University of Minnesota campuses in Duluth and Minneapolis . Support leadership training to potential Minnesota pharmacist leaders .

Foundation Activities: Created the AWARxE campaign to educate communities and individuals on the dangers of prescription medications . Hosts the annual Herbie Cup to raise money for the Herb and Addie Whittemore scholarship . Developed the Student Education Fund to invest in our future pharmacy leaders . Awards scholarships annually to pharmacy students at the University of Minnesota campuses in Duluth and Minneapolis . Helped bring the Meth Watch program to Minnesota to help educate consumers and retailers on meth awareness .

“We get closer to achieving our goals every day with your support...any level of support is appreciated.”

Minnesota Pharmacist n Winter 2012 35 advertising: minnesota pharmacist quarterly journal

The Minnesota Pharmacist is a quarterly journal publication of the Minnesota Pharmacists Association (MPhA) with a circula- tion of 1,800 . The leading information resource for pharmacy spring - April in Minnesota, each journal includes in-depth articles on clinical, • Advertising due March 15, 2012 practice, industry, management and legislative issues . summer - july approval & placement: All advertising is subject to pub- • Advertising due June 15, 2012 lisher’s approval . Acceptance of advertisement does not constitute endorsement, and is subject to space availability . To reserve space fall - october in an upcoming journal, submit an Advertising Purchase Request • Advertising due September 14, 2012 form by the indicated due date . Orders must be received before deadline to hold space . Please call ahead if you have deadline conflicts . Contact Anna Wrisky at the MPhA office for more informa- Errors: The publisher shall not be liable for slight changes or tion: annaw@ewald .com or 651-290-6298 . typographical errors which do not lessen the value of the adver- • $100 frequency discount available on annual reservation (4 tisement . The publisher shall not be liable for any other errors issues) . appearing in any advertisement unless the magazine received • MPhA meeting exhibitors receive $100 advertising credit corrected copy before the issue deadline with corrections plainly when placing an ad in the issue preceding the event . noted . Signed exhibiting confirmation notice must be received by our indemnification: All advertisements are accepted and office for discount to be effective. published on the representation that the advertiser and/or the advertising agency are authorized to publish the entire contents and subject matter thereon, as confirmed by verbal or written order from the person representing the advertiser and/or advertis- Ad size and Rates ing agency . The advertiser agrees to indemnify and hold the publisher and production company harmless from any and all liability, claims, demands or damages arising out of the advertising or on Size dimensions black & White CMYK behalf of the advertiser . Such indemnity includes the provision Full page 8 .5 x 11 $740 $1,470 of a defense to any actions or claims and the payment of cost and attorney’s fees in connection therewith . Half page 3 .75 x 9 .5 vertical $485 $1,215 7 .5 x 4 .75 horizontal $485 $1,215 supplying files: Files may be emailed or mailed to the MPhA office . Third page 2 .9 x 9 .5 vertical $430 $1,160 Preferred mailed formats: CD saved for MAC use . 7 .5 x 3 .125 horizontal $430 $1,160 Preferred email formats: High/Press quality PDF with proper color Fourth page 3 .75 x 4 .75 vertical $335 $1,065 separations . 4 .75 x 3 .75 horizontal $335 $1,065 Accepted file formats: High/Press quality PDF, EPS, TIF, or JPEG (maximum quality) . Eighth page 2 x 3 .5 vertical $200 N/A When supplying files other than PDF, you must include all original 3 .5 x 2 horizontal $200 N/A graphics used in file and all fonts used. Please ensure that your files color separate correctly . Classified over 75 words $50 N/A under 75 words $25 N/A minnesota pharmacist

2012 Editorial Calendar and submission dates The Leading Information Resource for Pharmacy in Minnesota

Editorial Advertisement Month/Issue Focus Deadline Deadline mails

spring Pharmacy Legislative Day Wrap March 1 March 15 April Mid-Session Report

summer PharmPAC Newsletter May 31 June 15 July Annual Meeting Wrap Session Wrap House of Delegates Report New MPhA Board Members

fall Fall Clinical Symposium Wrap August 31 September 15 October Promote Pharmacy Legislative Day Award Nomination Forms

WINTER Pharmacist Resource Guide December 1 December 15 January Ad size and Rates Year in Review AWARxE Update Size dimensions black & White CMYK Every issue President’s Desk Full page 8 .5 x 11 $740 $1,470 Executive’s Report Half page 3 .75 x 9 .5 vertical $485 $1,215 Public Affairs 7 .5 x 4 .75 horizontal $485 $1,215 Feature articles Third page 2 .9 x 9 .5 vertical $430 $1,160 MPhA featured member benefit 7 .5 x 3 .125 horizontal $430 $1,160 Pharmacy & the Law/Financial Forum Fourth page 3 .75 x 4 .75 vertical $335 $1,065 4 .75 x 3 .75 horizontal $335 $1,065 Exhibitors are eligible for a discounted advertising rate for the issue promoting the event. Eighth page 2 x 3 .5 vertical $200 N/A The Minnesota Pharmacist is a quarterly journal publication of the Minnesota Pharmacists Association (MPhA) . All advertising and 3 .5 x 2 horizontal $200 N/A feature articles are subject to publisher’s approval . Acceptance of advertisement or editorial content does not constitute endorsement, and Classified over 75 words $50 N/A is subject to space availability . under 75 words $25 N/A MPhA welcomes editorial content that has a direct link to professional managment, growth or inititives in the pharmacy field . To be considered for publication, submit your name (along with any connections to a specific product or company) with a sample or explanation of your editorial content to Anna Wrisky at annaw@ewald .com or fax to 651-290-2266 . Authors will be notified if their submissions are accepted for publication . All authors receive a complimentary copy of the issue containing their content .

Minnesota Pharmacist n Winter 2012 37 spring - April advertising request form • Advertising due March 15, 2012 summer - july • Advertising due June 15, 2012 minnesota pharmacist fall - october quarterly journal • Advertising due September 14, 2012

Company Advertising: ______

issue: Winter Spring Summer Fall Annual (4 issues) size: Full Half Third Fourth Eighth Classified: -75 / +75 Mail or Fax to Anna Wrisky color: Black (Eighth and Classified are black only) Full Color Spot Color Minnesota Pharmacists Association 1000 Westgate Drive • Suite 252 St . Paul, MN 55114 651-697-1771 • 651-290-2266 fax total advertising cost: $______

billing: Above Company Advertising Agency • Tear sheets will be supplied with invoice or receipts to the billing Firm: ______address provided . Address: ______

• $100 frequency discount per issue City: ______State: ______ZIP: ______on annual reservation (4 issues) . Contact Person: ______Phone: ______Fax: ______• MPhA meeting exhibitors receive $100 advertising credit on E-mail: ______orders when placed in the issue preceding the event . Signed payment: Invoice me Check enclosed Charge: MC / Visa / Amex / Discover exhibiting confirmation notice must be received by our office for discount number:______expiration:______to be effective. name on card:______3 or 4 digit code:______

• Include yourself on our jour- billing address:______nal mailing list by becoming an city:______state:______zip:______Associate Member! Annual subscriptions of $100 are signature:______also available . Invoice/ job number to reference (if applicable): ______• Questions? Contact Anna Wrisky at the MPhA office: annaw@ewald . This form will be used to secure space in MPhA’s 2012 journals and will act as an intent to com or 651-290-6298 . purchase advertising .

Name and Title (please print): ______Signature: ______Date: ______

38 Minnesota Pharmacist n Winter 2012 Two Great Ways to Earn Rewards With McKesson and Pace Alliance

Our dedication to your continued success as an independent pharmacy means making an impact on our industry, as well as your bottom line. That is why we’ve strengthened our relationship to deliver even greater value to McKesson Distribution customers who are members of Pace Alliance.

Eligible customers now have the opportunity to earn up to 13% in an additional monthly rebate on net McKesson OneStop Generics® purchases, while implementing valuable business- building solutions. Plus, as more Pace Alliance members become McKesson customers, the rebate percentages can get even higher.

Fewer Requirements, Perform at Your Peak Bigger Rewards with Health Mart® Pace and McKesson: The Pace Performance Rewards program now In addition to monthly rebates of up to 13% A Complete Solution for provides even greater rewards based on your (or more) on qualified OneStop purchases, Independent Pharmacy purchasing commitment. Not only have we Health Mart pharmacies can earn up to enhanced the rebates, but we’ve eased the $10,000 per year in technology rebates Since 1985, Pace Alliance has been requirements. So all Pace members who use through the Pace Peak Performance working on behalf of independent McKesson as their primary wholesaler and Rewards program.1 Pace Peak Performance community pharmacies to help participate in the following valuable McKesson Rewards is available exclusively to Health Mart them decrease costs, while programs have an opportunity to earn greater franchisees who participate in: generating revenue for state rewards: pharmacy organizations. – McKesson’s Generics Purchasing Today, Pace is owned by 19 – McKesson’s Generics Purchasing Rewards Program state pharmacy organizations Rewards Program – ASAPSM and ASAP PlusSM generics and is dedicated to protecting – ASAPSM and ASAP PlusSM generics autoship programs and advancing the profession autoship programs for community pharmacies – GenericsConnectSM, a regularly scheduled nationwide. – GenericsConnectSM, a regularly scheduled call from a dedicated generics specialist call from a dedicated generics specialist – Controlled Substance Ordering System (CSOS) Together, Pace and McKesson are Controlled Substance Ordering System (CSOS) – – AccessHealth® dedicated to helping community pharmacies thrive in today’s – McKesson Reimbursement Advantage marketplace. As part of this continued commitment to your success, Pace members can benefit “By strengthening our partnership with McKesson, Pace Alliance can from McKesson’s revenue-building continue to focus on our advocacy efforts and deliver even greater value solutions and cost-reducing to our members.” programs and services.

Curtis J. Woods, R.Ph. President and CEO Pace Alliance

Dakota Drug Inc. As the Midwest’s only Independent Drug 1101 Lund Boulevard Wholesaler, Dakota Drug has grown and developed by Anoka, MN 55303 addressing the needs of you, the Community Pharmacist, and by phone (763) 432-4333 providing assistance to ensure your success . fax (763) 421-0661 www .dakdrug .com We are committed to personal service and welcome the opportunity to assist you.

The Upper Midwest’s Independent Healthcare Distributor